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This study shows the relevance of neuropsychology to the field of bipolar disorder and 
“mood” disorders in general. This is a new field of research, and those who study and 
treat patients with bipolar disorder have only gradually learned to understand the deficits 
that result from cognitive impairment, even when the patient seems to be doing well in 
terms of mood symptoms. My interest in cognition in bipolar disorder was awakened by 
my experiences as a neuropsychologist on the geriatric ward of a psychiatric hospital. 
The symptoms that are presented by bipolar patients in an acute manic or depressive 
phase can be overwhelming because they may range from florid psychotic mania with 
grandiose delusions to depression with mutism and catatonic features. In addition, these 
clinical symptoms are often part of an impressive life story, especially in elderly patients.
People are generally inclined to think that if an elderly person makes a mistake or forgets 
something, he or she might be deteriorating mentally, whereas if a younger person makes 
the same mistake, it is accepted as “normal”. Similarly, a doctor who has treated a patient 
with bipolar disorder for a long time may wonder whether the patient is suffering from 
dementia when he reaches a certain age. Could the patient’s recent mood episode have an 
organic cause, i.e. dementia? Careful neuropsychological assessment might indeed reveal 
cognitive impairment in several domains. However, such an assessment might also show 
that this cognitive impairment differs from the profile of cognitive impairment of patients 
with dementia. While some patients are quite aware of their cognitive impairment, 
others, surprisingly, do not complain at all about their cognitive functioning. It is often 
difficult to distinguish between cognitive deficits consistent with bipolar disorder and 
age-appropriate cognitive decline in older adults. Let us consider the following case from 
clinical practice.
Case Study
A retired 71-year-old male dentist with a history of Bipolar I disorder and myocardial 
infarction was referred for neuropsychological evaluation. He suffered his first episode 
of manic psychosis at the age of 32, and he was hospitalized five to six times after that. 
Over the preceding twenty years, his pharmacotherapy regime had consisted of taking 
lithium (500 mg/day) and temazepam. He had never shown psychomotor disturbances 
or Parkinsonistic symptoms. He had been euthymic for a long time but during a follow-up 
appointment his psychiatrist noted that although there were no clear depressive signs, 
there was an unusual slowing of movement and thoughts. He denied having problems 
with attention or memory. His MMSE score was 28. The psychiatrist wondered whether 
this slowness could be the result of a degenerative (subcortical) illness. 
In the neuropsychological examination his scores for speed, divided attention, category 
fluency and mental flexibility were low average to average. His scores for visuoconstruction 
tests were in the high average range. His scores for learning and retention of information 
(with perfect recognition), interference, planning and letter fluency were below normal. 
It was concluded that there were no indications of the slowness or motor disturbances 
seen in subcortical illnesses such as Parkinson’s disease, but that this patient showed the 
mild cognitive impairments that are commonly found in patients with bipolar disorder.
Based on the results of this examination, the patient’s psychiatrist reassessed his 
medication, including his cardiovascular regimen. The patient was given additional 
information on how to deal with his memory problems and a follow-up examination was 
planned for a year later.
Neuropsychologists working with elderly psychiatric patients are confronted with a 
kind of jigsaw puzzle. The variables that directly and indirectly affect cognition and that 
interact with each other are diverse and become more and more complex over a patient’s 
lifetime . In the case of bipolar disorder these variables include: premorbid deficits and 
personality traits, genetic contributions, psychotic symptoms, bipolar subtype, subclinical 
symptomatology, hormonal factors, homocysteine level, duration of illness, length of time 
euthymic, number of episodes, number of hospitalizations, age at onset of illness, aging 
process, comorbid diseases, insight, activation, medication and substance abuse (Vieta et 
al., 2008).
Some cognitive deficits may be present before the onset of the illness and represent a 
genetic liability. Illness-related factors may also contribute to a patient’s cognitive course. 
However, the relative contribution of these pre- and post-onset factors is unknown (Bora 
et al.. 2009). Many older patients have neurological risk factors or illnesses that may 
also influence cognitive functioning (Robinson and Ferrier, 2006). Age of onset is an all 
important factor: does the illness that a patient develops at a later age have a different 
etiology and different symptoms, and does it require different treatment (Martinez-Aran 
2004)? Some of the pieces of this puzzle have been identified, but putting them together 
remains a challenge. This is important because persistent cognitive deficits seem to be 
closely linked to social and occupational functioning (Bowie at al., 2006; Depp et al., 2007). 
This is true of several psychiatric disorders such as schizophrenia and bipolar disorder 
(Wingo et al., 2009). In these cases, cognitive deficits may better predict poor outcome 
than affective symptoms. The importance of cognitive functioning in bipolar disorder can 
affect all aspects of clinical management, from assessment to pharmalogical strategies, 
especially if cognitive deficits are ignored or misidentified.
In this first chapter, the aims and outline of this thesis will be presented after an 
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introduction of the relevance of bipolar disorder in later life, a brief history of bipolar 
disorder and cognition, and a short overview of measurements of cognitive function.
Bipolar disorder in later life
Bipolar disorder is a disease characterized by cycles of depression and mania. There are 
two varying degrees of bipolar disorder: Bipolar I, described as “a clinical course that is 
characterized by the occurrence of one or more Manic Episodes or Mixed Episodes”, and 
Bipolar II, described as “a clinical course that is characterized by the occurrence of one or 
more Major Depressive Episodes accompanied by at least one Hypomanic Episode” (DSM-
IV-TR American Psychiatric Association, 1994).
Major depressive episodes are periods when a person undergoes a number of symptoms, 
including mood changes, loss of interest or pleasure in his/her usual activities, diminished 
ability to think or concentrate, insomnia or hypersomnia, and recurrent thoughts of death 
or suicidal ideation. Manic episodes are periods when a person’s mood is abnormally and 
persistently elevated and/or irritated, and symptoms include inflated self-esteem, flight 
of ideas, decreased need for sleep, inability to concentrate, and engaging in potentially 
risky activities. The episode must be severe enough to impair occupational functioning 
or necessitate hospitalization to prevent the patient harming himself or others. Mixed 
episodes are periods when a person fluctuates between symptoms of both a manic 
episode and a major depressive episode nearly every day in a one-week period. Hypomanic 
episodes are very similar to manic episodes but they are less severe and hospitalization is 
therefore not necessary.
According to the APA Guideline for Treatment of Bipolar Disorder, acute episodes of 
mania are usually treated with a mood stabilizer (lithium or valproate) and antipsychotic 
medication. Once the patient has been stabilized, the continuing need for antipsychotic 
medication in addition to mood stabilizers may be reassessed. For acute depressive 
episodes a mood stabilizer is recommended, sometimes in conjunction with an anti-
depressant. With several specific exceptions (such as benzodiazepines), most psychotropic 
agents cause only relatively mild cognitive problems in patients with bipolar disorder 
(Goldberg, 2008).
Bipolar disorder is a serious and chronic mental illness. It is associated with substantial 
functional and quality-of-life impairments, increased rates of suicide, and high financial 
costs. Bipolar disorder occurs in 1.9 % of the Dutch population, affecting almost 300.000 
people (Kupka and Regeer, 2007). Over the next 15 years the number of people over the age 
of 80 will increase from 3.9 to 5.2%. This reflects a general aging trend in the population 
and has important implications for the delivery of health services (van den Broek et al., 
2008). The prevalence of bipolar disorder in individuals over the age of 60 ranges from 
0.1 to 0.5 % (Oostervink and van Gerven, 2008). Of the patients who were admitted to the 
geriatric wards of psychiatric hospitals, 8 to 10% were diagnosed as suffering from bipolar 
disorder (Depp and Jeste, 2004). 
Bipolar disorder and cognition
Kraepelin introduced the distinction between dementia praecox and manic depressive 
insanity (1899). Dementia praecox was later called schizophrenia, which was characterized 
by a severe disturbance of cognitive functioning after onset and a progressively 
degenerative course. All subgroups of affective disorders were united under the term 
manic depressive illness, which was characterized by a complete recovery between 
periods of illness. Kraepelin’s influence dominated until the late 1960s, when a dichotomy 
between unipolar and bipolar disorders was introduced. 
Since then, many studies have demonstrated the presence of a wide range of 
neuropsychological deficits in patients with depression and in bipolar patients. However, 
the majority of these studies were confounded by the failure to control for residual affective 
symptoms (Ferrier et al., 1999). Over the last 10 years more studies have adequately 
controlled for this potential confounder. A growing body of evidence suggests that adult 
patients with a bipolar disorder show specific cognitive impairments, even when they are 
in a euthymic state. A recent meta-analysis of neuropsychological function in euthymic 
bipolar patients provides evidence of a trait-related neuropsychological deficit involving 
attention/processing speed, memory and executive function (Torres et al., 2007). However, 
there is still little information about bipolar disorder in later life (Depp and Jeste, 2004).
Over the last 15 years, imaging studies have attempted to evaluate the networks that 
are involved in cognition in both the grey and the white matter of the brain. Patients 
with bipolar disorder showed a larger decline in hippocampal, fusiform, and cerebellar 
grey matter density over a four-year period than control subjects (Moorhead et al., 2007). 
Reductions in temporal lobe grey matter correlated with a decline in cognitive function 
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(verbal IQ). A major problem with imaging studies on this topic is that the effects of aging 
on the brain may influence the results. The areas most sensitive to volume loss with aging 
are those structures associated with the anterior limbic network. Interestingly, older 
patients with bipolar disorder showed more grey matter volume deficits in inferior frontal 
lobe areas, which include structures identified as part of the anterior limbic network 
(Beyer et al., 2009). Late-onset bipolar disorder showed increased rates of white matter 
hyperintensities (Tamashiro et al., 2008).
In conclusion, many possible mechanisms may underlie cognitive deficits in older adult 
patients with bipolar disorder. They may include genetic abnormalities that present early 
during the illness and cause cognitive deficits, as is the case for schizophrenia. These 
deficits can also present later in life, when they are combined with effects of the illness, 
such as repeated mood episodes, medical comorbidity, substance use, (pharmaco)therapy 
or aging. In addition, the brains of bipolar patients may be more vulnerable to toxic effects 
throughout their life.
Neuropsychology, dimensions in cognition and measurement of 
cognitive functions
Cognition can be defined as the mental process of knowing, and it includes aspects 
such as awareness, perception, reasoning and judgement. The field of neuropsychology 
focuses primarily on assessing aspects of cognition via a variety of pencil-and-paper and 
computerized tests to assess brain functions. Several domains of cognitive functions are 
differentiated (Spreen and Strauss, 1998; Lezak et al., 2004).
1. Attention: the most basic cognitive construct, reflecting conscious processing of 
information; it involves alertness, mental focus, concentration and the ability to 
selectively and flexibly process some information in the environment at the expense 
of other information.
2. Executive function: a broad term that refers to a collection of higher-level cognitive 
processes, including planning, working memory, strategy development, inhibitory 
control, and cognitive flexibility.
3. Memory: the ability to retain learned information and knowledge of past events and 
experiences and to retrieve them. There are three stages of memory: encoding, storage, 
and retrieval.
4. Motivation: conscious effortful cognitive processing results from sufficient mental 
effort. Some authors have considered poor mental health a core symptom of 
schizophrenia, and it should be taken into account during the neuropsychological 
assessment of psychiatric patients in general (Gorissen et al, 2005).
5. Verbal functions: consist of different modalities, i.e. speech, reading, writing, and 
comprehension. For the production of normal speech different component processes 
are necessary (vocabulary, word retrieval, grammatical and phonological encoding, 
articulation).
6. Visuoconstruction: this combines perceptual activity with motor response and always 
has a spatial component.
The domains that have provided the most consistent evidence for impairment in bipolar 
patients are: attention, verbal learning and memory, and executive functions (see 1.2). Tests 
on these cognitive domains should be included in a research battery of tests for bipolar 
patients. In this study we included visuoconstruction because bipolar patients seem to 
rely less on organizational strategies during copying than controls (Deckersbach et al., 
2004). In addition, language-related abilities may be more impaired in elderly euthymic 
patients with bipolar disorder (Radinovic et al., 2008), and we therefore included tests for 
this domain.
Neuropsychological assessment is characterized by measuring cognitive deficits. The 
determination of deficits rests on the comparison between what can be assumed to be 
a patient’s characteristic premorbid level of cognitive functioning and the test scores he 
attains. A comparison is made for each test score. By chance alone, a certain amount of 
variation (scatter) between test scores can be expected for even the most normal person. 
Different tests are therefore used and if significant discrepancies occur for more than one 
test score, a pattern of deficit may emerge (the deficit measurement paradigm; Lezak et 
al., 2004). The different tests used to assess each cognitive domain in this study are shown 
in Table 1.
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It has been hypothesized that the interplay between cortical regions responsible for 
cognitive control (the frontal cortex) and the limbic areas that are critical to emotional 
response is impaired in patients with bipolar disorder. The impairment of this interplay 
may be responsible for the core symptoms of the disease (Savitz et al., 2005). 
Figure 1. Schematic diagram of the anterior limbic network as a model of the expression of 
bipolar symptoms. (a) ‘Iterative’ prefrontal subcortical network that samples inputs from other 
brain regions to modulate appropriate behavioral responses. (b) Limbic areas that modulate (e.g. 
amygdala) or express the response (e.g. hypothalamus). DLPFC=dorsolateral prefrontal cortex; 
MD=mediodorsal nucleus; SGPFC=subgenual prefrontal cortex
From: Strakowksi et al. (2005)
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Table 1   Neuropsychological tests used in this study to assess different cognitive domains
Domain Test Function measured Description Associated region
Attention Trail making Test Rapid visual scanning  Subject is asked to join numbers 1-25 FC
 Part A Psychomotor speed in order
 Digit forwards Auditory attention Subject is asked to repeat a sequence FC
  Attention span numbers
 Digit backwards Auditory attention On hearing a sequence of numbers DLPFC
  Working memory the subject says them in reversed order
Executive Mazes Forward planning Subject is asked to plan his way out DLPFC
function   of a maze
 Trail Making Test Attentional shifting Subject is presented a page containing FC
 Part B Psychomotor speed 1-12 and letters A-L. Time is taken to
   join circles in alternating order
   (1-A-2-B etc.)
 Stroop test Selective attention Subject is asked to name ink colour of ACC
  Interference control colour of ingruent colour words
Memory List learning Episodic memory Consists of 5 representations; subject TC
  Immediate and is asked to repeat as many words as he
  delayed recall, can. Free retention after 10-15 minutes
  cued recall and recall from recognition list
Motivation ASTM Immediate recall Subject has to read and remember -
  Mental effort 5 words, then solve an arithmetic
   problem and fi nally choose
   from 5 words those 3 words that
   were also part of the fi rst 5 words
Verbal Category naming Semantic processing Subject is asked to name as many TC
function  Mental fl exibility animals and occupations in 1 minute FC
 COWA Semantic processing Subject is asked to name words TC
  Mental fl exibility beginning with D-A-T in 1 minute DLPFC
Visuo- Copying Visuospatial con- Subject is asked to copy from series of POC
Construction  struction abilities geometric fi gures
 Clock drawing Visuospatial Draw clock face and set time POC
  construction abilities to “10 past 11” FC
  Planning
FC=frontal cortex   ASTM=Amsterdam Short Term Memory Test
ACC=anterior cingulate cortex  COWA=Controlled Word Association Test
DLPFC=dorsolateral prefrontal cortex
POC=parietal occipital cortex
TC=temporal cortex
Cortical limbic structures include the amygdala, hippocampus and parahippocampal 
gyrus, ventral striatum, insula, cingulate cortex, and orbitofrontal cortex. Because 
of reciprocal connectivity between the areas, it is likely that dysfunction within this 
system leads to both the emotional dysregulation that characterizes the illness and the 
concomitant neurocognitive impairment that is common in bipolar disorder (see Figure 1).
Available neuroimaging studies indicate that older patients with a bipolar disorder show 
increased signs of atrophy and cerebral vascular lesions compared with normal aged-
matched controls. Late-onset groups had a higher risk of neurological impairment (see 
1.2). This might suggest that the anterior limbic network is abnormal in patients with 
bipolar disorder (Strakowksi et al., 2005). However, it is unclear how these brain changes 
arise, whether they are related directly to psychopathology or to lifestyle factors, and 
whether they are specific to bipolar disorder (Depp and Jeste 2004). More research is 
therefore needed to ascertain how the interaction between, and the relative contributions 
of bipolar disorder characteristics, vascular burdens, iatrogenic effects and alcohol causes 
brain changes and the cognitive impairment associated with these changes.
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Chapter   1
Aims and outline of the study
This study aims to investigate cognitive function in elderly patients with bipolar disorder. 
Specific research questions are:
1. Do older patients with an early onset Bipolar-I disorder who are in a euthymic state exhibit 
cognitive deficits compared with normal elderly people?
This question is addressed in Chapter 2, in which a pilot study is described with 15 patients 
and 15 matched controls.
2. Do older patients with bipolar disorder who are in a euthymic state exhibit cognitive 
deficits compared with normal elderly people?
In Chapter 3, a large sample of 119 patients with early- and late-onset Bipolar-I and Bipolar-
II disorder were compared with 78 healthy controls.
3. Do late-onset bipolar patients show more cognitive decline than early-onset bipolar 
patients?
In Chapter 3, 59 early- onset (< 40 year) patients were compared with 60 late onset 
patients (>40 year). 
4. How is cognitive functioning influenced by illness-related factors, medication and general 
health? 
Chapter 4 focuses on identifying the variables that influence cognition in a group of 119 
patients. We investigated the following risk factors: demographic characteristics, bipolar 
illness characteristics, vascular burden and potential toxic effects of medication and 
alcohol.
5. Do subjective cognitive complaints predict lower scores for cognitive tests?
In Chapter 5 we show how 101 euthymic elderly bipolar patients and 74 healthy controls 
were assessed, using the Cognitive Failure Questionnaire to determine subjective 
cognitive complaints. Due to cognitive decline bipolar patients may be less effective in 
their ability to monitor and detect their own cognitive functioning. The role of frontal 
dysfunction in particular was examined.
6. Is cognitive impairment progressive among older patients?
In Chapter 6 the results of a follow-up study are described. The rates of cognitive decline 
in 64 patients and 42 comparison subjects the rates of cognitive decline were analysed 
after two years.
Finally, the results of the study are discussed in Chapter 7.
22 23
ReferencesChapter   1
•  Martínez-Aran A, Vieta E, Reinares M, et al. Cognitive function across manic or hypomanic, 
depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004, 161: 262-270.
•  Moorhead TWJ, McKirdy J, Sussman JED Progressive gray matter loss in patients with 
bipolar disorder. Biol Psychiatr 2007, 62, 894-900.
•  Oostervink F, Gerven, H van. Ouderen. In: Kupka RW, Knoppert E en Nolen W (Eds) 
Handboek Bipolaire Stoornissen. Utrecht, Tijdstroom, 2008.
•  Radanovic M, Nunes PV, Gattaz WF, Forlenza OV Language impairment in euthymic, 
elderly patients with bipolar disorder but no dementia. International Psychogeriatrics 
2008, 20, 687-696.
•  Robinson LF, Ferrier EN. Evolution of cognitive impairment in bipolar disorder: a systematic 
review of cross-sectional evidence. Bipolar Disord 2006, 8, 103-116.
•  Savitz J, Solms M, Ramesar R, 2005. Neuropsychological dysfunction in bipolar affective 
disorder: a critical opinion. Bipolar Disord 7: 216-235.
•  Spreen O, Strauss E: Compendium of Neurological Tests: Administration, Norms and 
Commentary, 2nd edition. New York, Oxford University Press, 1998.
•  Strakowksi SM, Delbello MP, Adler CM, The functional neuroanatomy of bipolar disorder: 
a review of neuroimaging findings. Mol Psychiatry 2005, 10, 105-116.
•  Tamashiro, J.H., Zung, S., Zanetti, M.V., de Castro, C.C., Vallada, H., Busatto, G.F. et al. 
Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar 
Disord 2008, 10, 765-775.
•  Torres IJ, Boudreau VG, Yatham LN Neuropsychological functioning in euthymic bipolar 
disorder: a meta-analysis. Acta Psychiatr Scand, 2007, 116, 17-26.
•  Vieta, E, Martinez-Aran, A., Goldberg, JJ Cognition across the life span : Clinical implications 
for older adults with bipolar disorder. In: Goldberg, J.F. and Burdick, K.E. (Eds.) Cognitive 
Dysfunction in Bipolar Disorder – a Guide for Clinicians. American Psychiatric Publishing 
Inc., Washington DC, 2008.
•  Wingo AP, Harvey PD, Baldessarini RJ. Neurocognitive impairment in bipolar patients: 
functional implications. Bipolar Disord 2009, 11, 113-125.
References
•  American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 
fourth edition. Washington, 1994.
•  Beyer JB, Kuchibhatla M, Payne M, et al. Gray and white matter brain volumes in older 
adults with bipolar disorder. Int J Ger Psychiatry 2009, 24, 1445-1452.
•  Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder : A meta-
analysis of neuropsychological deficits in euthymic patients and their first-degree 
relatives. J of Affect Disord 2009, 1-20.
•  Bowie CR, Reichenberg A, Patterson TL et al. Determinants of real-world functional 
performance in schizophrenia subjects: correlations with cognition, functional capacity, 
and symptoms. Am J Psychiatry 2006, 163, 418-425.
•  Broek, L van den, Jong A de, Duin, C van. Regionale bevolkings, allochtone en 
huishoudensprognose tot 2025. Den Haag/Voorburg. Centraal Bureau voor de Statistiek, 
2008.
•  Deckersbach T, Savage CR, Reilly-Harrington N Episodic memory impairment in bipolar 
disorder and obsessive-compulsive disorder: the role of memory strategies. Bipolar 
Disord 2004, 6, 233-244.
•  Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord 2004; 
6: 343-367.
•  Depp CA, Moore DJ, Sitzer et al. Neurocognitive impairment in middle aged and older 
adults with bipolar disorder: comparison to schizophrenia and normal comparison 
subjects. J Affect Disord 2007, 101, 201-209.
•  Ferrier IN, Stanton BR, Kelly TP. Neuropsychological function in euthymic patients with 
bipolar disorder. Br J Psychiatry 1999, 175: 246-251.
•  Goldberg, F.G. Adverse cognitive effects of psychotropic medications. In: Goldberg, J.F. 
and Burdick, K.E. (Eds.) Cognitive Dysfunction in Bipolar Disorder – a Guide for Clinicians. 
American Psychiatric Publishing Inc., Washington DC, 2008.
•  Gorissen M, Sanz JC, Schmand B. Effort and cognition in schizophrenia patients. 
Schizophrenia Res. 2005, 78, 199-208.
•  Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärtze. 3, Aufl. Barth, Leipzig, 
1899.
•  Kupka RW, Regeer EJ. Bipolaire stemmingsstoornissen. Ned Tijdschr Geneeskd 2007, 151 
(41) 2256-2260.
•  Lezak MD, Howieson DB, Loring DW: Neuropsychological Assessment, 4rd Edition. New 
York, Oxford Univesrity Press, 2004.
Chapter 2
Cognitive functioning in 
elderly patients with early 
onset bipolar disorder
Sigfried N.T.M. Schouws, Jeroen B. Zoeteman, 
Hannie C. Comijs, Max L. Stek and Aartjan T.F. Beekman
International Journal of Geriatric Psychiatry 2007, 856-861
Chapter   2
26
Cognitive functioning in elderly patients with early onset bipolar disorder
27
Abstract
Background: Very little is known about the long term cognitive sequelae of bipolar disorder.
Aim: To investigate neuropsychological functioning in older euthymic persons with early 
onset bipolar disorder.
Method: Fifteen older patients (age >60) with an early onset (<50 years) bipolar-I disorder 
in a euthymic mood were tested using a comprehensive neuropsychological test battery. 
Neuropsychological functioning was compared with that of a sex, age and education-
matched group of 15 comparison subjects without mood disorders or memory complaints.
Results: Bipolar subjects scored lower than comparison subjects on selective attention, 
verbal memory, verbal fluency and mental effort tests. 
Conclusions: The findings suggest that euthymic bipolar patients are impaired across a 
range of cognitive domains. This could represent a trait-like cognitive disability related 
to the disease, as the impairments are comparable with those found in younger bipolar 
patients. 
Introduction
Recent studies suggest that adult patients with a bipolar disorder show specific cognitive 
impairments, even when they are in a euthymic state. It is unclear whether the impaired 
cognitive functioning is related to a toxic disease process or that a genetically driven 
population variation in critical neural networks underpin both the neuro cognitive and 
affective symptoms of bipolar disorder (Savitz et al., 2005). If bipolar patients develop 
cognitive deficits in the course or as a consequence of their disorder, one would expect 
more pronounced deficits in later life. Because the research with older bipolar patients 
is scarce, the aim of the present study is to compare the cognitive functioning of a 
group of older bipolar patients with normal controls. It is important to include patients 
in a euthymic state, otherwise depression related cognitive disorders will be prominent. 
Furthermore it is important to study patients with early onset bipolar illness (before age 
50), because late onset disorders are often associated with organic cerebral disturbances 
(Van Gerpen et al, 1999) which may lead to cognitive deficits. 
Method
Sample
Fifteen older patients (>60 years) with bipolar-I disorder with an early onset (< 50 years), 
who were currently euthymic were included in this study. Most research studies refer to 
late-onset bipolar illness as that with a first episode beginning at age 50 or older (Goodwin 
& Jamison, 1990). Patients were recruited from outpatient clinics in Amsterdam after they 
were given verbal and written information about the study. The subjects who entered the 
study were reported to be euthymic for at least three weeks by their psychiatrist based 
on clinical judgement. Patients with a history of alcohol abuse or current substance abuse 
or dependence, patients with neurodegenerative disorders and patients with clinical 
symptoms that were above cut-off were excluded from this study. The control group 
consisted of 15 persons who were matched for sex, age, education and type of somatic 
condition. They had no current or lifetime history of psychiatric or addiction disorders or 
recent memory complaints. The control group was recruited from neighbourhood centres 
for elderly people and the local newspaper. Approval was obtained from the institutional 
ethics committee for conducting the study and all subjects gave written informed consent.
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Measurements
Educational level was assessed by a Dutch scoring system consisting of an 7-point scale, 
ranging from unfinished primary education (level 1) to university education (level 7). 
Clinical assessment consisted of the Structured Clinical Interview for DSM-IV (SCID) (First 
et al., 1996), Center for Epidemiologic Studies Depression Scale (CES-D) (Radloff, 1977) and 
Young Mania Rating Scale (YMRS) (Young et al., 1978). Illness characteristics such as age of 
onset and medication were derived from patient interviews and hospital medical records. 
Serum levels of mood stabilisers were not available. Pre morbid intelligence was estimated 
using the Dutch Reading Test for Adults (NLV), the Dutch version of the New Adult Reading 
Test (NART) (Nelson and O’Connell, 1978). The Mini Mental State Examination (MMSE) 
(Folstein et al., 1975) was used to provide an overall assessment of cognitive functioning. 
All subjects completed a comprehensive battery of neuropsychological tests covering 
four cognitive domains. Tests were administered according to standard instructions and 
took about an hour to complete. Tasks were given in the same order for all subjects. The 
instruments for each domain were as follows:
a)  Psychomotor performance and mental effort
Trail Making Test part A (Reitan, 1958): This measures psychomotor speed and is recorded 
in seconds, higher scores means lower speed.
The Amsterdam Short Term Memory Test (ASTM) (Schmand et al., 1998): This 
was developed as a symptom validity test and is sensitive to subtle forms of 
underperformance and mental effort. For the current study we used a short form of 
this test, which consisted of the first ten items. Total correct responses were analysed, 
higher scores indicate better performance.
b)  Attention and executive functioning
Digit Span subtest of the Wechsler Adult Intelligence Scale (WAIS-III) (Wechsler, 1980): 
Next to auditory attention and short-term retention capacity, this test assesses the 
ability to manipulate the information in verbal working memory. Raw scores for direct 
and reverse order were analysed. Higher scores indicate better performance on this 
test.
Modified version of the Stroop Color Word Test (Golden, 1978):  Part 3 measures the ability 
to change demands and suppress a habitual response in favour of an unusual one. The 
interference score is measured in seconds, higher scores indicate more interference.
Trail Making Test part B (Reitan, 1958): The results reflect the ability to shift strategy and 
assess executive function and visual spatial working memory. It is recorded in seconds, 
higher scores means lower speed.
Control Oral Word Association Test (COWAT) (Benton, 1976): This test was used to 
evaluate verbal fluency, which is also a sensitive measure of frontal executive function, 
because it requires the subject to generate their own strategy. Total correct responses 
were analysed, higher scores indicate better performance.
Animal and Occupation Naming subtest of the Groningen Intelligence Test (GIT) (Luteijn 
and van der Ploeg, 1983): This test measures semantic memory. Total correct responses 
were analysed, higher scores indicate better performance.
Mazes (1 to 4) subtest of the Wechsler Intelligence Scale for Children (WISC) (Wechsler, 
1976): This test was used to evaluate planning ability. This is recorded in seconds, higher 
scores means lower speed.
Rule Shift Cards subtest of the Behavorial Assessment of the Dysexecutive Syndrome 
(BADS) (Wilson et al., 1996): Measures the ability to change an established pattern 
of responding. A weighted score is obtained from the number of faults and time of 
execution, higher scores indicate better performance.
c)  Learning and memory
The 10 Words Test, a modified version of the Auditory Verbal Learning Test (Rey, 1964): 
The total number of learned words and recalled words were analysed, higher scores 
indicate better performances. Recognition faults were recorded, higher scores indicate 
poorer performance.
d)  Visuo constructional ability:
Figure Copying subtest of the Amsterdam Dementia Screening Test (ADS6) (Lindeboom 
and Jonker, 1989): This test was used to evaluate visuo graphic abilities. Total number 
of correct drawn copies responses were analysed, higher scores indicate better 
performance.
Clock Drawing (Shulman et al., 1993): This test is not only sensitive for visuo spatial 
abilities but also for planning functions. A 6-point scoring system is used from the 
best (point 1= well executed drawing, hands in correct position) to the worst (point 6 
= irrelevant or no attempt).
Statistical Analyses
Data (raw test scores) were analysed using the Statistical Package of the Social Sciences 
(SPSS version 11.0). Differences between groups were tested with independent samples 
t-tests. Two-tailed comparison with conventional significance levels (p<.05) were used. 
Effects sizes were calculated by means of Cohen’s d. Differences for variables containing 
a skewed distribution were tested by a non parametric test (Mann-Whitney U test). 
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When significant group differences were found Pearson ’s product moment correlation 
coefficients were employed to analyse relationships between test performances and 
severity of illness (p<0.05).
Results 
Group mean performances and statistical comparisons for all demographic and mood 
measures are summarised in Table 1. There was no significant difference for age, education, 
estimated pre morbid IQ, MMSE and clinical rating scale for depression between the 
bipolar subjects and the comparison subjects. In patients the mania rating score was 
significantly higher than in controls. However, as required at inclusion (euthymic state) 
the level of symptoms among bipolar patients was very low, and within normal ranges. 
Table 1.  Demographic and clinical characteristics
Control Group 
(n=15)
Patient Group
(n=15)
T P
Demographic characteristics
Gender (female/male) 8/7 8/7
Age, years: mean (SD) 72.53 (7.84) 73.13 (8.82) 0.19 0.84
Education1 : mean (SD) 5.47 (1.19) 5.47 (1.06) 0.00 1.00
 Premorbid IQ: mean (SD) 113.27 (7.69) 114.67 (7.59) 0.50 0.96
MMSE score: mean (SD) 29.33 (0.97) 29.00 (1.07) - 0.89 0.38
Mood rating scores
CES-D 7.80 (6.0) 6.80 (5.20) - 4.89 0.63
YMRS 0.07 (0.26) 1.27 (2.09) 2.21 0.03
Clinical characteristics
Diagnosis DSM-IV (SCID)
- Bipolar I recent episode hypomanic
- Bipolar I recent episode depressed
- Rapid cycling
5
9
1
Medication
- None
- Lithium
- Other mood stabiliser 
- Other psychopharmaca
1
9
2
12
Age at illness onset, years
- mean (SD)
- range
33.47 (1.36)
17-49
Number of admissions hospital
- mean (SD)
- range
5.87 (5.05)
0-20
CES-D, Center for Epidemiologic Studies Depression Scale; MMSE, Mini-Mental State Examination; 
SCID, Structured Clinical Interview for DSM-IV; YMRS, Young Mania rating Scale.
1 educational level was assesed by a Dutch scoring system consisting of an 7-point scale, ranging from unfi nished 
primary education (level 1) to university education (level 7)
Table 2.  Neuropsychological performances in euthymic patients with bipolar disorder and controls: means (SD)
Measure Control Group 
(n=15)
Patient Group
(n=15)
T P Effect 
size
Psychomotor performances and 
mental effort
Trail Making test part A 51.57 (26.17) 67.87 (25.08) 1.71 0.09 0.84
ASTM item 1 to 10 29.13 (0.74) 28.27 (0.96) -2.76 0.01 0.99
Attention and executive function
Trail making Test part B 111.60 (61.19) 145.69 (41.43) 1.69 0.10 0.85
Stroop Color Word test1 46.40 (22.47) 71.60 (24.02) 2.97 0.00 0.84
Controlled word association test
       Letters D-A-T
       Animal naming
       Occupation naming
37.00 (10.77)
23.13 (7.21)
18.07 (5.40)
23.60 (10.23)
17.33 (4.73)
14.27 (5.08)
-3.48
-2.60
-1.98
0.00
0.01
0.06
0.86
0.90
0.89
Digits Forward 8.80 (2.18) 8.13 (2.13) -0.85 0.40 0.96
Digits Backward 6.27 (1.79) 5.40 (1.55) -1.42 0.17 0.92
Mazes (1 to 4)
        Planning time 109.60 (59.24) 155.29 (59.07) 2.08 0.05 0.82
Rule Shift Cards2 3.67 (0.49) 3.07 (0.88) 0.95
Learning and memory
10 words test
        Learning (trials1 to 5)
        Retention
        Recognition errors2
36.80 (4.71)
6.67 (1.54)
0.53 (0.83)
29.07 (6.98)
4.93 (1.91)
1.47 (1.30)
-3.55
-2.74
0.00
0.01
0.96
0.90
0.43
Visuo-constructional ability
Figure Copying ADS62 12.80 (0.41) 12.60 (0.51) 0.99
Clock drawing2 1.33 (0.72) 1.33 (0.72) 0.78
ADS6, Amsterdam Dementia Screening test; ASTM, Amsterdam Short Term Memory Test
1This is a short form  consisting of reading the fi rst 4 lines
2Mann-Whitney U test: for Mazes U=80.5 p=0.16; for Rule Shift Cards U=67.5 p=0.06; for 10 Word Test 
recognition errors U=63.5 p=0.03; for Figure Copying U=90.0 p=0.24; for Clock Drawing U=112.5 p=1.00
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Descriptive data and statistical comparisons for all cognitive measures are summarised 
in Table 2. Patients and controls significantly differed on the learning, retention and 
recognition condition of the Auditory Verbal Learning Test, the Amsterdam Short Term 
Memory Test, animal naming and letter fluency of the Controlled Word Association Task 
and the Stroop Color Word Task. The effect size of the cognitive measures indicate large 
effects (d>0.8). Although the patients were slower than the controls the scores on Part 
A of the Trail Making Test were not significantly higher. In our bipolar group the number 
of prior hospitalizations and current level of mania symptoms were not significantly 
correlated with poor cognitive performance (see Table 3). With regard to correlations 
between depression measures and cognitive performance, CES-D scores correlated only 
with letter fluency. Patients reporting psychotic episodes in the past (n=7) did not differ 
from the group (n=8) who did not. 
Table 3.  Correlations between illness characteristics and impaired neuropsychological performances in 
euthymic patients with bipolar disorder
Measure Number 
admissions
CES-D YMRS
Mental effort
ASTM item 1 to 10 -0.36 0.10 -0.05
Attention and executive function
Stroop Color Word test1 0.22 -0.26 -0.20
Controlled word association test
       Letters D-A-T
       Animal naming
0.01
-0.17
0.57*
0.27
0.18
0.04
Declarative memory
10 words test
        Learning (trials1 to 5)
        Retention
        Recognition errors
0.13
0.50
-0.17
0.17
0.31
0.30
-0.22
-0.02
-0.34
ASTM, Amsterdam Short Term Memory Test
1This is a short form  consisting of reading the fi rst 4 lines
*p<0.05
Discussion
Our group of older early onset bipolar-I patients were impaired across a range of cognitive 
domains, including selective attention and verbal fluency (both aspects of executive 
functioning), verbal memory and mental effort. Olley et al. (2005) have suggested that 
reduced cognitive effort may explain reduced memory functioning in bipolar disorder, 
which can be confirmed by the results of the present study. We found that mental effort 
was reduced in bipolar patients. Patients were also slower than controls but although 
effect sizes were large, these measures did not reach level of significance. The differences 
between patients and controls were not attributable to symptoms of depression, as both 
groups did not differ according depressive symptoms. Severity of illness, as measured by 
the number of admissions in psychiatric hospitals, the occurrence of a psychotic episode 
in the past, or the current level of mania symptoms was not significantly correlated with 
cognitive performance.
Our findings are consistent with a growing body of evidence that bipolar patients 
experience cognitive deficits during mood stable episodes too . They are impaired across a 
range of cognitive domains, including attention, executive functioning, verbal declarative 
memory and psychomotor speed (Thompson et al., 2005; Martinez-Aran et al., 2004; Clark 
et al., 2002; Zubieta et al. 2001; Rubinsztein et al., 2000; Ferrier et al., 1999). Bipolar patients 
with a more severe prior course of illness and a greater number of affective episodes 
had more impaired neuropsychological functioning (Denicoff et al., 1999; Quraishi and 
Frangou, 2002). However contrary to expectations, white matter lesions as described in 
Magnetic Resonance Imaging (MRI) studies probably do not underlie the cognitive deficits 
in euthymic bipolar patients (Krabbendam et al., 2000; Bearden et al., 2001). 
Burt et al. (2000) and Savard et al. (1980) investigating neuropsychological performance 
among elderly bipolar patients, found a greater detoriation in cognitive function 
associated with age over the course of their illness. However, they studied patients 
regardless of the state they were in. As it is generally known that depression symptoms 
influence cognitive functioning, especially in older persons, it is not clear whether the 
association they found was related to the depressive symptoms in particular or were 
specific for bipolar disorders. In the one existing study with older bipolar patients in a 
euthymic state a significant proportion did indeed exhibit neuropsychological deficits 
(Gildengers et al., 2004). However, this study included both early (before age 50) and late 
onset bipolar disorders. 
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A strong point of the current study is that, as a comprehensive review shows ( Malhi et 
al., 2006), for the first time older patients with early onset bipolar disorder, who were 
tested when euthymic during a minimum period of 3 weeks, were compared with controls 
on a range of cognitive domains. Although the sample size is modest, the differences 
between bipolar patients and controls were large enough to be statistically significant. 
This supports the notion that differences found are not only statistically significant, but 
also clinically relevant. There is a small chance that we found some spurious findings (type 
one error) due to multiple comparisons. We did not apply the Bonferroni correction as 
the chance of finding a type one error is very small (one of 20) and the results in our 
study are not unexpected and consistent with other research to date (Perneger, 1998). 
A limitation of the study is that the effect of medication on test performance may have 
biased the interpretation of neuropsychological tests. On one hand several studies did 
not find definite associations between the use of lithium and neuropsychological test 
performance (Clark et al., 2002; Zubieta et al. 2001; Rubinsztein et al., 2000). On the 
other hand lithium has been associated by Pachet and Wisniewski (2003) with poorer 
performance on tests of memory and motor speed. As most of the patients were not 
receiving monotherapy other psychopharmaca could also have had potential cognitive 
side effects, although the use of benzodiazepines, known for cognitive side effects was 
virtually absent. The present findings may also have some limitations with regard to 
attrition. The cognitive functioning of the persons who refused to participate in the study 
was unknown. Because only a few persons refused to participate we do however not 
expect an important effect of selection bias.
Our findings with older adults are in line with the cognitive deficits that are found in 
younger adults (Bearden et al., 2001). This may suggest a trait-related dysregulation, 
causing bipolar patients to have cognitive deficits, even when euthymic and regardless of 
their age. Further follow-up studies in larger groups of patients who are euthymic over a 
long period are required to confirm these findings. Clinical implications are that cognitive 
deficits may have severely impact on social and occupational functioning (Martinez-
Aran et al., 2004; Zubieta et al., 2001). Furthermore, compliance to treatment regimens 
could be severely compromised by cognitive deficits and may demand adaptation of 
treatment strategies. More research is required to examine if graduate bipolar patients 
do indeed experience problems in everyday life and if neuropsychological and psycho 
educational rehabilitation can help to improve functioning. Longitudinal studies are 
warranted to determine whether the course of the cognitive impairments is progressive, 
related to structural changes in the brain, the use of medication or to other factors. 
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Abstract
Background: Late onset disorders are often associated with cerebral disfunctioning and 
cognitive impairment in elderly patients. It is unknown whether the age of onset affects 
cognition in patients with bipolar disorder. The authors compare cognition and clinical 
characteristics of early and late onset bipolar patients in a stable and euthymic condition.
Method: One hundred and nineteen 119 older patients (age >60) with an early-(<40 years) 
or late-onset bipolar disorder and a group of 78 comparison subjects were extensively 
tested for cognitive functioning.
Results: Bipolar subjects scored lower on most cognitive measures. The late-onset patients 
were more impaired in psychomotor performance and mental flexibility than the early-
onset patients. These differences could not be explained by differences in exposure to 
cerebrovascular risk factors.
Conclusions: Older patients with bipolar disorder have substantial cognitive impairments. 
Late-onset bipolar disorder is associated with more severe cognitive impairment than 
early-onset bipolar disorder. For clinical practice, it is important to develop treatment 
strategies which take this into account.
Introduction
There is a growing body of evidence that aged patients with bipolar disorder have impaired 
cognitive functions across a range of cognitive domains (Young et al, 2006). These cognitive 
impairments have important clinical implications, such as more functional disability and 
difficulties in adherence to medical regimes for older patients compared to younger and 
middle aged patients (Depp et al, 2005). As a result, older bipolar patients may require 
different health services. Although cognitive impairment may be a trait vulnerability 
factor for bipolar disorder, regardless of age, two other important factors may also have 
a negative impact on cognition in elderly patients. First, even small degrees of residual 
manic or depressive symptomatology can partially account for the cognitive impairment 
observed in bipolar patients, and most studies are confounded by the failure to control for 
residual affective symptoms (Ferrier et al, 1999; Clark et al 2002) . Secondly, elderly patients 
with a bipolar disorder form a heterogeneous group, including early-onset patients who 
developed their illness during early adulthood and late-onset patients who experienced 
their first mood episode at an older age (Depp and Jeste, 2004). Late onset disorders are 
often associated with vascular and neurodegenerative changes (Gildengers et al, 2008), 
which may also lead to cognitive deficits (van Gerpen et al, 1999). In such cases, bipolar 
patients do not develop cognitive deficits in the course or as a consequence of their 
disorder, but these deficits develop as a consequence of vascular and neurodegenerative 
changes. 
We sought to clarify this issue by examining neuropsychological functioning in a group 
of elderly patients with bipolar disorder who were euthymic at the time of testing, and 
comparing them with a group of “normal” elderly people. Our aim was to investigate the 
associations between cognition and clinical characteristics in a group of early and late 
onset bipolar patients. We hypothesized that late onset bipolar patients would show 
more cognitive decline than early onset bipolar patients, and that these differences would 
be greater than the differences between the early onset group and the comparison group.
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Methods
Sample
We included were older patients (>60 years) with bipolar-I and bipolar-II disorder who were 
currently euthymic. Because most of the bipolar patients were living in the community, 
we focused on outpatients who we recruited from outpatient clinics in four regions of 
the Netherlands. With the help of the Dutch Bipolar Patient Association, we also recruited 
extra patients. Eligible subjects were reported to be euthymic for at least 3 weeks by their 
psychiatrist, and none of the patients who were included had received electroconvulsive 
therapy (ECT) in the previous year. Great care was taken to exclude patients with current 
mood symptoms, which could influence cognition. We also excluded patients with a 
primary diagnosis of alcohol dependence or substance abuse and patients with a clinical 
diagnosis of dementia. The comparison group was recruited from community centres 
for elderly people and advertisements in local newspapers.  This group consisted of 78 
persons, who had no current or lifetime history of psychiatric or addiction disorders or 
recent memory complaints. Written informed consent was obtained from all participants.
With respect to age of onset, we defined late onset as a first affective episode in patients 
over 40 years of age, as this was the median age of the first mood episode for the total 
sample in this study. 
In the literature, there is a lack of clear consensus concerning the age limits used to 
differentiate “early onset” from “late onset” (Subramaniam et al, 2007). In samples of 
patients with different ages, the median age at onset has generally been used as the 
criterion. Furthermore, there are two potential ages of onset: the age of the first affective 
episode and the age of the first manic episode, but only a few studies have used the first 
manic episode as the criterion. 
Measurements
Bipolar disorder was clinically diagnosed with the Structured Clinical Interview for 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID) (First 
et al, 1996). Current symptoms of depression were assessed according to the Centre 
for Epidemiologic Studies Depression Scale (CES-D) (Radloff, 1977), and current mania 
symptoms according to the Young Mania Rating Scale (YMRS) (Young et al, 1978). Illness 
characteristics, such as age of onset and medication, were derived from patient interviews 
and hospital medical records. If the patient had received previous psychiatric treatment, 
the psychiatric records were examined. For the present study a cerebrovascular risk score 
(range 0-2; 0=zero risk factors, 1=one risk factor and 2 = more than one risk factor) was 
determined as follows: respondents were asked whether they currently or previously 
had any of the following chronic diseases or disease events: circulatory system diseases 
(myocardial infarction, angina pectoris, heart failure, cardiac arrhythmia), hypertension, 
history of ischemic attack or stroke, diabetes. The answers were coded either as ‘yes’ or ‘no’ 
for each of these diseases. Premorbid intelligence was estimated with the Dutch Reading 
Test for Adults (NLV), which is the Dutch version of the New Adult Reading Test (NART) 
(Nelson and O’Connell, 1978). The Mini Mental State Examination (MMSE) (Folstein et al, 
1975) was used to obtain a global assessment of cognitive functioning.
All participants also completed a comprehensive battery of neuropsychological tests 
covering the following four cognitive domains:
a)   Psychomotor Performance and Mental Effort: The Trailmaking Test Part A (Reitan, 1958) 
and the Amsterdam Short-Term Memory Test (ASTM) (Schmand and Lindeboom, 2005)
b)   Attention and Executive Functioning: The Digit Span subtest of the Wechsler Adult 
Intelligence Scale (WAIS-III) (Wechsler, 1981), the Modified version of the Stroop 
Color Word Test (Golden, 1978), the Trailmaking Test Part B (Reitan, 1958), the Control 
Oral Word Association Test (COWAT) (Benton and Hamsher, 1976), the Animal and 
Occupation Naming  subtest of the Groningen Intelligence Test (GIT) (Luteijn and 
Ploeg, 1983), the Mazes (1-4)  subtest of the  Wechsler Intelligence Scale for Children 
(WISC) (Wechsler, 1976), and the Rule Shift Cards subtest of the Behavorial Assessment 
of the Dysexecutive Syndrome (Wilson et al. 1996).
c)   Learning and Memory: The 10 Words Test, which is a modified version of the Auditory 
Verbal Learning Test (Rey, 1964).
d)   Visuo Constructional Ability: The figure-copying subtest of the Amsterdam Dementia 
Screening Test (ADS6) (Lindeboom and Jonker, 1989), and Clock-drawing (Shulman et 
al, 1993).
Statistical Analyses
Differences between groups were analysed with analysis of variance (ANOVA), with age, 
gender, education, and cerebrovascular risk factors as covariates. Two-tailed comparisons 
were used, and to decrease the risk of Type I error, all results at level p≤0.01 were considered 
to be significant. Effect sizes were calculated by means of η2 (Cohen, 1988) . Differences for 
variables containing a skewed distribution were tested by means of a nonparametric test 
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(Kruskal Wallis test). The data (raw test scores) were analysed using the Statistical Package 
of the Social Sciences (SPSS) version 14.0.
Results  
Demographic and clinical features
The demographic and clinical characteristics and the contrast between the early- and 
late-onset bipolar groups and the comparison group are presented in Table 1 (p.46). 
The patients with early- and late-onset bipolar disorder did not differ on any of the 
demographic variables studied, except for age: patients with an earlier onset were 
significantly younger than patients with a late onset and subjects in the comparison 
group. 
The mean age of onset for the early onset group was 27.6 years, while their first treatment 
started at the mean age of 31.1. The mean age of onset for the late onset group was 53.7 
years, and their first treatment started at the mean age of 55.5 years.  The early onset 
group was significantly more likely to have a family history of psychiatric illness (77% vs. 
52 %; X=9.33, p<0.01). The patients with early- and late-onset bipolar disorder did not differ 
with regard to diagnostic subtypes or number of previous episodes and were equally 
likely to have been admitted for treatment or to have experienced a mood episode with 
psychotic features. There was no significant difference in the MMSE scores. With regard 
to residual depressive symptoms, there were no differences between patients in the 
two bipolar groups, and no differences between the bipolar groups and the comparison 
groups. With regard to residual manic symptoms, the bipolar patient had significantly 
higher scores than the comparison group, but there were no differences between the 
early- and late-onset bipolar groups. According to the inclusion criteria (euthymic state), 
there were very few mood symptoms among the bipolar patients. The patients in both 
groups and the comparison group had a similar burden of medical illness, as was reflected 
in the index of cerebrovascular risk factors. As would be expected, patients with earlier 
onset bipolar disorder had been taking lithium significantly longer than  patients with 
late onset bipolar disorder. The early-onset group was significantly more likely to have 
been treated with ECT in the past (15% vs. 3%, X=205.9, p<0.01).
Cognitive features
Descriptive data and statistical comparisons for all cognitive measures are summarized 
in Table 2 (p.47). Both the early and the late onset bipolar groups differed from the 
comparison group with regard to the learning, retention and recognition condition of 
the Auditory Verbal Learning Test, the Amsterdam Short Term Memory Test, Part A and 
B of the Trailmaking Test, the Mazes, the Rule Shift Cards of the Behavorial Assesment of 
the Dysexecutive Syndrome, the Animal and Occupation naming, the letter fluency of the 
Controlled Word Association Task, and the Stroop Color Word Task. The effect sizes of the 
cognitive measures indicate large effects (η2>0.14) except for mental effort, which indicate 
a medium effect (η2<0.15). The late-onset bipolar patients had significantly lower scores 
than the early-onset bipolar patients for Part A of the Trailmaking Test, the Occupation 
naming and the Rule Shift Cards. The effect sizes of the cognitive measures indicate 
small to medium effects (η2<0.15). There were substantial covariate effects for age and 
education, but virtually none for cardiovascular risk factors. 
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Table 1.  Demographic and clinical characteristics
Comparison
group
(n=78)
Early                    
onset          
(n=59)         
Late
onset
(n=60)
Between 
group
contrast
Age, years (SD) 1 71.86 (8,0) 68.41 (6,2) 72.32 (7,5) EO<CG,LO
Men, n (%)1 22 (28%) 28 (47%) 29 (48%) CG<EO,LO
Education2 5.29 (1.2) 5.19 (1.5) 4.87 (1.5)
Estimated premorbid IQ (SD) 111.63 (9.1) 109.90 (13.9) 105.40 (14.4)
Marital status, n (%)
 Married/living with someone 34 (43%) 24 (40%) 22 (37%)
 Divorced/separated 13 (17%) 13 (22%) 16 (27%)
 Widowed 20 (25%) 9 (15%) 15 (25%)
 Single 12 (15%) 11 (18%) 7 (12%)
Living arrangements on admission, n 
(% )
 Home without supervision 78 (100%) 51 (86%) 46 (77%)
 Home with supervision 0 6 (10%) 11 (18%)
 Intermediate care facility 0 2 (4%) 2 (4%)
Age at onset, years (SD) 1 27.61 (6.9) 53.78 (9.4) EO<LO
Fist treatment, years (SD) 1 31.14 (9.6) 55.50 (10.9) EO<LO
DSM Diagnosis, n (%)
- Bipolar I last episode depressive 25 (42%) 24 (40%)
- Bipolar I last episode manic 9 (15%) 19 (32%)
- Bipolar I last episode NS 4 (7%)  3  (5%)
- Bipolar II 7 (12%) 12 (20%)
- Rapid cycling 4  (7%) 2 (3%)
With psychotic features, n (%) 44 (74%) 35 (58%)
Family history psychiatric illness, n (%)1 41 (77%) 25 (52%) EO>LO
Number of admissions, n (SD) 3.97 (4.2) 2.58 (3.8)
Number of depressive episodes (SD) 5.52 (7.6) 3.15 (3.0)
Number of manic episodes 7.35 (14.6) 3.89 (3.4)
Duration euthymic state, months (SD) 48,39 (71.6) 55.50 (66.4)
MMSE, total score (SD) 27.87 (5.9) 28.27 (1.5) 27.45 (4.2)
CES-D, total score (SD) 8.33 (5.5) 10.68 (6.6) 8.85 (7.8)
YMRS, total score (SD) 1 0.6 (0.43) 1.32 (1.6) 0.87 (1.6) CG<EO,LO
Index of cerebrovascular risk factors, n 
(%)
0 risk factors 47 (60%) 33 (56%) 29 (48%)
1 risk factors 24 (31%) 22 (37%) 20 (33%)
> 2 risk factors 7 (9%) 4 (7%) 11 (18%)
Medications, n (%)
-None 3 (5%) 4 (7%)
- On lithium, n (%) 40 (68%) 39 (65%)
-On other mood stabilizer, n (%) 16 (27%) 20 (32%)
-On other psychopharmaca, n (%) 28 (47%) 29 (48%)
ECT in medical history, n (%)1 9 (15%) 2 (3%) EO>LO
CES-D: Center for Epidemiologic Studies Depression Scale; MMSE: Mini-Mental State Examination; SCID: Structured 
Clinical Interview for DSM-IV; YMRS: Young Mania Rating Scale; ECT: electroconvulsive therapy; EO: Early onset; 
LO: Late onset; CG: Comparison group.
1ANOVA for age df=2, F=297.04, p=0.01; for YMRS F=27.99, df=2, p<0.01; for age of onset F=297.36, df=1, p<0.01;
for fi rst treatment F=166.22, df=1, p<0.01
Pearson χ2 for ECT χ2 =205.97, df=6, p<0.01; for family history psychiatric illness χ2=9.32, df=2, p<0.01; for gender χ2=7.61, 
df=2, p=0.02
2 Educational level was assesed by a Dutch scoring system consisting of an 7-point scale, ranging from unfi nished 
primary education (level 1) to university education (level 7)
Table 2.  Neuropsychological performance in patients with early and late onset bipolar disorder and comparison group: mean (SD) and 
mixed group analysis of variance of neuropsychological functioning
Measure Comparison 
group
(N=78)
 Early
 onset
(N=59)
Late
onset
(N=60)     
Patients vs
comparison 
group
Early 
vs 
late
Between 
group
contrast
F P η2 F P η2
Psychomotor 
performance
- Trailmaking Test 
Part A, s
46.97
 (19.6)
63.03
 (34.3)
89.78
 (68.3)
13.55 <0.01 0.30 7.2 0.01 0.06 CG>EO>LO
Mental effort
- ASTM 1 t/m 10 29.00
 (1.0)
28.03
 (1.6)
26.77
 (5.6)
 4.41 <0.01 0.12 2.79 0.09 0.02 CG>EO,LO
Attention and 
executive function
- Digits forward 5.73
 (0.9)
5.32
 (0.9)
5.08
 (0.9)
7.74 <0.01 0.19 1.74 0.19 0.01 CG>EO, LO
- Digits backward 4.71
 (1.1)
3.93
 (0.9)
3.88
 (1.0)
11.27 <0.01 0.26 0.07 0.79 <0.01 CG>EO,LO
- Trailmaking Test 
part B, s
109.68
 (58.7)
175.41
 (118.6)
218.10
 (129.4)
14.87 <0.01 0.32 3.54 0.06 <0.01 CG>EO,LO
- Stroop Color Word 
test 1,s
45.31
 (12.8)
61.51
 (29.4)
71.40
 (33.5)
13.21 <0.01 0.29 2.91 0.09 0.02 CG>EO,LO
- D-A-T 35.75
 (10.7)
25.66
 (11.0)
21.93
 (11.5)
23.06 <0.01 0.42 3.22 0.07 0.02 CG>EO,LO
- Animal naming 23.23
 (6.0)
18.76
 (5.1)
17.83
 (5.6)
15.14 <0.01 0.34 0.87 0.35 <0.01 CG>EO,LO
- Occupation 
naming
17.41
 (4.9)
15.39
 (5.4)
12.35
 (4.8)
11.43 <0.01 0.26 10.32 <0.00 0.08 CG>EO>LO
- Mazes, s 121.41
(95.32)
156.64
 (108.8)
211.38
 (140.4)
14.26 <0.01 0.31 5.63 0.02 0.05 CG>EO>LO
- Rule Shift Cards 
BADS
1.06
 (1.6)
1.53
 (2.2)
2.70
 (2.8)
 9.37 <0.01 0.22 6.42 0.01 0.05 CG>EO>LO
Declarative 
memory 
10 Words Test  
- Learning (trials 
1-5)
37.35
 (5.7)
30.23 
(6.5)
27.73
 (7.3)
25.91 <0.01 0.45 3.84 0.05 0.03 CG>EO,LO
- Retention 6.74
 (1.9)
4.58
 (1.9)
4.45
 (2.3)
16.99 <0.01 0.34 0.47 0.75 <0.01 CG>EO,LO
- Recognition2 19.26
 (0.9)
18.61
 (1.3)
18.00
 (2.6)
CG>EO,LO
Visuo construction
- Copying ADS62 12.37
 (1.6)
12.27
 (1.9)
12.33
 (0.8)
- Clockdrawing2 1.41
 (0.8)
1.42
 (0.8)
1.67
 (1.1)
ASTM: Amsterdam Short-Term Memory Test;  BADS: Behavorial Assessment of the Dysexecutive Syndrome; ADS6: 
Amsterdam Dementia Screening test; EO: Early onset; LO: Late onset; CG: Comparison group.
1This is a short form  consisting of reading the fi rst 4 lines
2Kruskal Wallis test patients versus comparison group: for 10 Words Test recognition errors χ2=34.14, p<0.01; for Figure-
copying χ2=14.79 p=0.13; for Clockdrawing χ2=7.76 p=0.65; Mann Whitney U-test early versus late: for 10 Word Test 
recognition errors Z=0.87 p=0.38; for Figure-copying Z=-1.08 p=0.28; for Clockdrawing Z=-1.17 p=0.24 
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involvement of fronto-subcortical parts of the brain (speed and mental flexibility). 
This provides indirect evidence that late-onset bipolar patients may have greater 
frontostriatal dysfunction than early-onset patients, which could be due to a different 
neuropathology. From another viewpoint, early-onset patients more often have a family 
history of psychiatric illness, so early onset may have genetic causes and late onset 
may be etiologically different (Gunning-Dixon et al, 2008). A recent study (Beyer et al, 
2004) showed that a decrease in right caudate volume is found in older bipolar patients, 
compared to normal subjects, but this was not associated with the age of onset. This 
study did not control for the presence of cardiovascular diseases. De Asis et al. (2006) 
found frontal deep white matter hyperintensities on magnetic resonance imaging in 
older persons with bipolar disorder. Higher right frontal signal hyperintensities were 
associated with the onset of mania at a later age. It is difficult to compare these results 
with the results of our study, because their study population consisted of hospitalized 
patients whose cognitive status and medical comorbidities were not assessed.
Factors that may limit the generalizability of our study include the distribution of 
demographic variables. The patients with an earlier onset were significantly younger than 
the patients with a late onset and the comparison group, but when age was statistically 
controlled for in our study all the cognitive differences between the early and the late 
onset group remained. A second limitation is the difficulty of ascertaining the exact age 
at onset and comparing our findings with those of studies with different criteria for age 
of onset. Most of the recent studies have used the age at which the first mood episode 
that met full diagnostic criteria was reported, and this also applies to our study. Whatever 
the method chosen, recall bias may influence the results. If more cognitively disabled 
patients were less likely to remember earlier illness episodes (which seems plausible), 
this would bias the results in the direction of more cognitive decline in the late-onset 
bipolar patients. However, we found only relatively small differences between the early- 
and late-onset bipolar groups, so these differences may in reality be even smaller. A 
third issue is the influence of residual symptoms. Both of the bipolar groups had few, 
but significantly more residual manic symptoms than the comparison group. However, 
the level of residual manic symptoms in the bipolar groups was low, and there were no 
differences between the early- and the late-onset groups. Moreover, residual depressive 
symptoms are known to have more impact on cognitive performance than residual manic 
symptoms (Malhi et al, 2007) , and in the present study, no differences were found with 
regard to residual depressive symptoms. Therefore, it is unlikely that residual symptoms 
have had any significant influence on the results. Another limitation of the study is that 
the effect of medication on test performance may have biased the interpretation of the 
Discussion
To our knowledge, this is the first study with a large study population of patients with 
bipolar disorder, both early- and late-onset, in which cognitive functioning is studied and 
compared with a group of normal elderly people. We hypothesized that late onset bipolar 
patients would demonstrate more cognitive decline than early-onset bipolar patients, 
and that these differences would be greater than the differences between the early-onset 
group and the comparison group. Late onset bipolar patients were, indeed, more impaired 
with regard to psychomotor performance, word fluency and mental flexibility than early-
onset bipolar patients, but these impairments were not attributable to age, education, or 
cerebrovascular risk factors. The results suggest that differences between early- and late-
onset bipolar patients do exist, but they are not as great as is often suggested. In terms of 
cognitive sequelae, the distinction between early and late onset bipolar disorder does not 
seem to indicate two different types of disorder. However, these data also show that the 
cognitive functioning of older bipolar patients is substantially compromised in areas that 
are important, both for daily functioning and for compliance with treatment. 
We found that early-onset bipolar patients are more likely to have a family history of 
psychiatric illness and have more often been treated with ECT. Despite these differences 
in clinical characteristics, our early- and late-onset bipolar patients did not differ with 
regard to diagnostic subtypes, number of previous episodes or admissions, the presence 
of psychotic features or pharmacological treatment and both groups had the same 
burden of  cerebrovascular risk factors. Our findings are in line with those of Wylie et al. 
(1999), who found a higher rate of family history of psychiatric illness in the early-onset 
group, but they are in contrast with the consistently higher rate of neurological illness in 
late-onset mania and bipolar disorder that Depp and Jeste (2004) found in their review. 
Neurological illness has been defined differently in the various studies, e.g. “organic brain 
syndrome” and “cerebrovascular risk/burden”. In our study cerebrovascular risk was not 
measured physically, but asked about in a standardized questionnaire for the participants. 
Patients with dementia were excluded from the study. In conclusion, we did not find a 
higher exposure to cerebrovascular risk factors in the late-onset group. Therefore, the 
differences between the early- and late-onset groups could not be explained by underlying 
cerebrovascular risk, as defined in our study.  
Both bipolar groups demonstrated substantial neuropsychological impairments, when 
compared with the comparison group. The late-onset bipolar patients were more 
impaired than the early-onset bipolar patients in the performance of tests that suggest 
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results on neuropsychological tests. On the one hand, several studies found no definite 
associations between the use of lithium and neuropsychological test performance (Young 
et al, 2004; Zubieta et al, 2001; Rubinsztein et al, 2000). On the other hand, Pachet and 
Wisniewski (2003) found that lithium was associated with poorer performance on tests 
of memory and motor speed. As most of the patients were not receiving monotherapy 
other psychopharmaca could also have had potential cognitive side-effects, although the 
use of benzodiazepines, which are known to cause cognitive side effects, was virtually 
absent. The present findings may also have some  limitations with regard to the selection 
procedure. However, only a very small number of eligible persons were unwilling to 
participate, so we do not expect any important effect of selection bias. Furthermore, we 
had no information about the age of onset among patients who were demented, but 
given the small number of these patients we do not expect any major differences.
Major clinical implications from the present study are that older patients may need 
different treatment strategies than younger patients, because compliance with treatment 
could be compromised by substantial cognitive deficits. Furthermore, more information 
for bipolar patients, and specific psycho educational rehabilitation programs may be 
necessary, because cognitive deficits could have severe impact on their psychosocial 
functioning and performance (Malhi et al, 2007; Gildengers et al, 2007). Longitudinal 
studies are needed to determine whether cognitive impairment is progressive, and to 
study the factors that  determine the rate of cognitive decline among older patients. 
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Abstract
Objective: Cognitive impairment in elderly bipolar patients persists during euthymic state, 
yet the aetiology of such impairment is not well understood.  The objective of this study 
is to identify factors contributing to cognitive impairment in elderly patients with bipolar 
disorder.
Method: 119 older patients (age >60) with bipolar I or II disorder in a euthymic state 
were extensively tested on cognitive functioning including attention, memory, 
visuoconstruction, executive function and verbal fluency with regard to potential risk 
factors.
Results: Pearson’s correlations show that health related factors, medication and illness 
characteristics are associated with cognitive impairment in several cognitive domains: 
attention, memory, visuoconstruction, executive function and verbal fluency. More 
vascular burden factors are related to poorer outcome of cognitive functioning. Patients 
with lithium pharmacotherapy performed worse compared to those with other mood 
stabilizers, but this was no longer significant in hierarchical regression analysis. 
Conclusions: In elderly bipolar patients, more vascular risk factors and more hospital 
admissions are associated with more cognitive impairment. 
Introduction
Many studies have demonstrated that aged patients with bipolar disorder have impaired 
functioning across a range of cognitive domains (Young et al., 2006), even after resolution 
of mood symptoms. Cognitive dysfunction in elderly patients with bipolar disorder is 
consistent with results obtained in younger patients with bipolar disorder, which include 
deficits in attention, memory and executive functioning (Robinson and Ferrier, 2008).
However, cognitive decline is not an inevitable consequence of bipolar disorder. There is 
a great variability in the level of cognitive functioning among elderly bipolar patients. 
It appears that, while some patients may be more prone to long term cognitive decline, 
other patients retain normal functioning. Cognitive impairment may have many adverse 
effects, including hampering compliance to treatment strategies, so effort should be 
made to prevent such a decline. However, the aetiology of cognitive impairment in bipolar 
disorder is not well understood. A number of factors may, directly or indirectly, influence 
cognitive functioning. Firstly, the potential neurotoxic effects of the disorder itself (Vieta 
et al., 2008). For instance cognitive impairment is found to be associated with a worse 
prior course of illness, particularly the number of manic episodes, hospitalizations and the 
length of illness (Kessing & Andersen, 2004). Also the presence of subsyndromal symptoms 
appears to influence the general level of cognitive functioning of bipolar patients. Even 
few residual depressive symptoms are known to have impact on cognitive performance 
(Ferrier et al. 1999; Clark et al., 2002). Secondly, neurodegenerative changes that can 
accompany the normal aging process may explain cognitive decline in bipolar patients. 
Vascular risk factors may cause cognitive impairment, as there is a higher cerebrovascular 
risk in elderly bipolar patients and the late onset group has a higher vascular risk 
compared to the patients with an early onset (Subramaniam et al., 2007). With respect to 
neurodegenerative disorders some studies suggest that the risk of developing dementia 
seems to increase with the number of episodes in bipolar disorder. Thirdly, potential toxic 
agents, like medication and the consumption of alcohol may play a role. Pharmacotherapy, 
especially lithium, has been associated with poorer performance on tests of memory and 
motor speed (Pachet and Wisniewski, 2003). It has also been shown that alcohol abuse 
which is highly prevalent in individuals with bipolar disorder, worsens the course of illness 
and may also cause cognitive deficits (van Gorp et al., 1998). 
The purpose of this study was to investigate whether demographic characteristics, 
bipolar illness characteristics, vascular burden and potential toxic effects of medication 
and alcohol were associated with functioning in important neuropsychological domains 
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such as attention, verbal memory, visuoconstruction, executive functioning and verbal 
fluency. We hypothesized that bipolar patients with a longer and more severe course of 
illness and more cerebrovascular risk factors have greater cognitive impairment and that 
these different factors independently influence cognitive functioning.
Method
Sample
Included were 119 older patients (>60 years) with bipolar-I and bipolar-II disorder, who 
were currently euthymic (Schouws et al., 2009). Since most of the bipolar patients reside 
in the community, we focused on outpatients. Patients were recruited from outpatient 
clinics in four regions in the Netherlands. With help form the Dutch bipolar patient 
association (VMDB, Association for Manic Depressives and their Relatives) extra patients 
were recruited. Extensive care was taken to exclude patients with current mood symptoms, 
which could influence cognition. Eligible subjects were reported to be euthymic for at 
least three weeks by their psychiatrist. Excluded were patients with a primary diagnosis of 
alcohol dependence or substance abuse and patients with dementia according to DSM-IV 
criteria. Lithium (66% of the patients), valproid acid and carbamazepine were the typical 
medications for the remitted patients in this study. Among the 119 patients only 7 subjects 
(6%) did not use any medication. Of the 119 patients 94 (79%) had a Bipolar I diagnosis, 
19 (16%) a Bipolar II diagnosis and 6 (5%) a rapid cycling disorder. The study was approved 
by the institutional review board and written informed consent was obtained from all 
subjects.
Measurements
Clinical diagnosis of bipolar disorder was reached using the Structured Clinical Interview 
for DSM-IV (SCID) (First et al., 1996). Current depressive symptoms were assessed using 
the Centre for Epidemiologic Studies Depression Scale (CES-D) (Radloff, 1977) and current 
mania symptoms with the Young Mania Rating Scale (YMRS) (Young et al., 1978). Illness 
characteristics such as age of onset and medication were derived from patient interviews 
and hospital medical records. In our analysis age of onset was defined as age at which 
the first mood episode occurred. The presence of somatic chronic diseases was assessed 
by asking respondents whether they currently or previously had any of the following 
chronic diseases or disease events: cardiac disease (including myocardial infarction), 
peripheral artherosclerosis, stroke, diabetes mellitus, COPD (asthma, chronic bronchitis 
or pulmonary emphysema), arthritis (rheumatoid arthritis or osteoarthritis) or cancer. 
Answers were coded as either ‘yes’ or ‘no’ for each of these diseases. Compared to general 
practitioner information, the accuracy of self-reports of these diseases was shown to 
be adequate and independent of cognitive impairment (Kriegsman et al. 1996). For this 
study a cerebrovascular risk score (range 0-2; 0=zero risk factors, 1=one risk factor and 2 = 
more than one risk factor) was determined as follows: respondents were asked whether 
they currently or previously had any of the following chronic diseases or disease events: 
disease of circulatory system (myocardial infarction, angina pectoris, heart failure, cardiac 
dysrhytmia), hypertension, history of ischemic attack or stroke and diabetes.  Answers 
were coded as either ‘yes’ or ‘no’ for each of these diseases. Premorbid intelligence was 
estimated using the Dutch Reading Test for Adults (NLV), the Dutch version of the New 
Adult Reading Test (NART) (Nelson an O’Connel, 1978). The Mini Mental State Examination 
(MMSE) (Folstein et al., 1975) was used to provide an overall assessment of cognitive 
functioning. 
All subjects completed a comprehensive battery of neuropsychological tests grouped into 
five cognitive domains.  
a)   Attention: Digit Span subtest of the Wechsler Adult Intelligence Scale (WAIS-III) 
(Wechsler, 1981), Trail Making Test Part A (Reitan, 1958) The Amsterdam Short Term 
Memory Test (ASTM) (Schmand and Lindeboom, 2005).
b)   Learning and memory: The 10 Words Test, a modified version of the Auditory Verbal 
Learning Test (Rey, 1964).
c)   Visuo constructional ability: Figure Copying subtest of the Amsterdam Dementia 
Screening Test (ADS6) (Lindeboom and Jonker, 1989), and Clock Drawing (Shulman et 
al., 1993).
d)   Executive functioning: Trail Making Test Part B (Reitan, 1958), Modified version of 
the Stroop Color Word Test (Golden, 1978), Mazes (1 to 4)  subtest of the  Wechsler 
Intelligence Scale for Children (WISC) (Wechsler, 1976), and the Rule Shift Cards subtest 
of the Behavorial Assessment of the Dysexecutive Syndrome (BADS) (Wilson et al., 
1996).
e)   Verbal fluency: Control Oral Word Association Test (COWAT) (Benton and Hamsher, 
1976), Animal and Occupation Naming  subtest of the Groningen Intelligence Test (GIT) 
(Luteijn and van der Ploeg, 1983).
60
Risk factors for cognitive impairment in elderly bipolar patients
61
Chapter   4
Statistical analyses
Composite scores for each neurocognitive domain were calculated by converting 
the subject’s raw scores to standardized z scores. The z scores were then summed in 
each domain to provide a single score. Higher scores indicated better neurocognitive 
performances. 
To test the impact of illness characteristics on cognitive functioning in bipolar patients, 
Pearson’s correlations and hierarchical regression analysis were carried out. Clinical 
variables that were hypothesized to influence cognitive performance were introduced in 
the models using a enter method. In model 1 sociodemographic factors were included in 
the analysis. In model 2 all illness characteristics were included in the analysis. In model 3 
vascular burden was included and in model 4 potential toxic agents (lithium and alcohol) 
were included in the analysis. In the final model we included all variables with p value < 
0.10, with and without age as confounding factor. Results at level p≤0.05 were considered 
to be significant. Analysis were done by using SPSS version 15.0.
Results
Sociodemographic and clinical characteristics are shown in Table 1. The neurocognitive 
function test scores included in the domains of attention, executive function, memory, 
visuoconstruction and verbal fluency are shown in Table 2. The low mean scores on the 
YMRS and CES-D demonstrate that all bipolar subjects were in a state of remission and 
had no residual symptoms. 
The associations between neurocognitive function and illness characteristics were 
calculated with Pearson’s correlations. The results indicate that age was significantly 
correlated with all neuropsychological measures as was premorbid intelligence (results 
not shown). Gender was significantly correlated with all measures except verbal fluency 
(Attention: r=-0.18, p=0.04; Memory r=0.20, p=0.03; Visuoconstruction: r=-0.21, p=0.02; 
Executive function: r=-0.23, p=0.01). The number of hospital admissions was significantly 
correlated with attention (r=-0.20, p=0.03), visuoconstruction (r=-0.23, p=0.01) and 
executive function (r=-0.23, p=0.01) and the number of vascular risk factors was 
significantly correlated with attention (r=-0.24, p=<0.01), memory (r=-0.26, p<0.01) and 
verbal fluency (r=-0.28, p <0.01). 
Table 1.  Sociodemographic and illness characteristics in patients with bipolar disorder
Mean (SD) Range
Sociodemographic characteristics
- Age (M, SD) 70.38 (7.18) 60-90
- Premorbid IQ (M,SD) 107.63 (14.28) 65-130
- Sex: male (N, %) 57 (47.9)
Ilnness characteristics
- MMSE score (M, SD) 28.20 (1.79) 21-30
-YMRS score (M, SD) 1.09 (1.67) 0-6
-CES-D score (M, SD) 9.76 (7.27) 0-30
- Hospital admissions  (M,SD) 3.61 (3.72) 0-16
-Depressive episodes (M, SD) 5.56 (10.59) 1-99
-Manic episodes, (M, SD) 4.28 (5.82) 1-50
-Psychotic episode (N, %) 79 (67.5)
-Months eythymic (M, SD) 51.97 (68.89) 1-336
-Duration illness (yrs, SD) 29,57 (14.83) 1-64
-Age at onset (yrs, SD) 40.81 (15.51) 17-77
-Age of fi rst psychiatric treatment (yrs, SD) 43.42 (15.97) 6-83
Vascular burden
-Vascular risk factors (M, SD) 0.63 (0.77) 0-4
Potential toxic agents
- Lithium (N, %) 79 (66.3)
- Alcohol (units per week) (M, SD) 5.13 (5.97) 0-19
Table 2.  Domain of neurocognitive function
Domain Test Mean (SD) Range
Attention  Digits Forward 5.20  (0.9) 4-8
 Digits backward 3.91 (1.0) 2-7
 ASTM 1 t/m 10 27.39 (4.2) 21-30
 Trail Making Test Part A, s 76.54 (55.6) 24-420
Memory 10 words test
 Learning (trials 1 to 5)  28.97 (7.0) 12-44
 Retention  4.51(2.2) 0-10
 Recognition  18.30(2.1) 3-20
Visuo-construction  Copying ADS6  12.30 (1.5) 9-13
 Clock Drawing  1.55 (1.0) 1-5
Executive function Trail Making Part B, s 196.93 (125.5) 52-420
 Stroop 66.50 (31.87) 28-206
 Mazes,s 184.24 (128.2) 52-500
 Rule Shift Cards BADS  2.12 (2.5) 0-10
Verbal fl uency  D-A-T 23.78 (11.4) 2-59
 Animal naming 18.29 (5.4) 6-33
 Occupation naming 13.86 (5.4) 2-30
ADS6: Amsterdam Dementia Screening test; ASTM: Amsterdam Short Term Memory Test; 
BADS: Behavorial Assessment of the Dysexecutive Syndrome.
1This is a short form  consisting of reading the fi rst 4 lines
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Manic symptoms were correlated only with poorer performance on visuoconstruction 
(r=-.025, p<0.01). Lithium was correlated with a worse performance on attention (r=0.29, 
p<0.01), visuoconstruction (r=0.21, p=0.02), executive function (r=0.31, p<0.01) and verbal 
fluency (r=0.23, p=0.01).
To identify the groups of factors that are independently associated with cognitive 
impairment, regression analysis were performed on the five cognitive domains with the 
factors of each different group of predictor variables (sociodemographic factors, illness 
characteristics, vascular burden an potential toxic agents) (Table 3).  Because age at onset 
of the first mood episode and duration of illness were highly correlated (r=-0.89, p <0.01), 
we analysed only the variable age of onset.
Age and premorbid IQ were significantly associated with performances on all cognitive 
functions. Older patients had a worse performance on all cognitive domains than younger 
ones and patients with a higher premorbid IQ performed better on all cognitive domains. 
Gender was significantly associated only with memory, women performing better than 
men on this task. Manic symptoms were associated with poorer visuoconstruction and 
a later age of onset was associated with poorer visuoconstruction, executive functions 
and verbal fluency. There was no significant association for other illness characteristics 
and performances on cognitive tests. Patients with more vascular risk factors had more 
difficulties with attention, memory and verbal fluency. Lithium and alcohol were not 
associated with performance on cognitive tests.
When all variables with p value <0.10 were entered without age as a confounding factor, 
only premorbid IQ, number of hospital admissions, manic symptoms and vascular risk 
factors remained significantly associated with cognitive performances (Table 4). When 
all variables with p value <0.10 were entered, including age, premorbid IQ remained 
significant with all cognitive domains except for memory. Furthermore, vascular risk 
factors remained significant with attention (B= -0.20; p=0.02 ), meaning that patients 
with more vascular burden had worse performance on attention, and number of hospital 
admissions with verbal fluency (B= 0.19 ; p= 0.04), meaning that patients with more 
hospital admissions had a worse performance on verbal fluency.
Table 3.  Summary of multiple regression analyses for illness characteristics, medication and health related factors making 
signifi cant contributions to the prediction of neuropsychological test performance
Attention Memory Visuoconstruction Executive 
function
Verbal fl uency
beta P beta p Beta P Beta P Beta P
I. Socio-demographic 
factors
-Age -0.22 <0.01 -0.25 <0.01 -0.34 <0.01 -0.38 <0.01 -0.34 <0.01
-Sex -0.03 0.72 0.33 <0.01 -0.07 0.37 -0.09 0.23 0.08 0.29
-Premorbid IQ 0.59 <0.01 0.42 <0.01 0.43 <0.01 0.45 <0.01 0.51 <0.01
II. Illness characteristics
-YMRS score -0.07 0.62 0.02 0.89 -0.30 0.01 -0.13 0.31 0.05 0.69
-CES-D score 0.01 0.95 0.03 0.83 0.10 0.35 0.05 0.68 -0.09 0.43
-Depressive episodes, n -0.08 0.62 0.26 0.09 -0.09 0.49 -0.07 0.62 0.07 0.62
-Manic episodes, n 0.12 0.43 -0.06 0.71 0.02 0.89 0.13 0.34 0.12 0.40
-Hospital admissions, n -0.19 0.23 0.05 0.73 -0.27 0.05 -0.23 0.19 -0.26 0.09
-Psychotic episode 0.01 0.91 -0.12 0.33 0.08 0.41 0.05 0.69 -0.27 0.07
-Months eythymic 0.13 0.36 0.15 0.27 0.13 0.27 0.24 0.06 0.18 0.17
-Age of onset -0.24 0.11 -0.13 0.35 -0.39 <0.01 -0.35 0.01 -0.32 0.02
III vascular burden
-Vascular risk factors -0.24 0.01 -0.26 <0.01 -0.05 0.62 -0.14 0.13 -0.28 <0.01
IV. Potential toxic agents
-Lithium 0.14 0.23 0.09 0.47 0.15 0.20 0.20 0.09 0.14 0.24
-Alcohol 0.22 0.06 0.19 0.12 0.03 0.80 0.07 0.56 0.13 0.26
Table 4.  Final stepwise logistic regression analysis, regardless of domain
Attention Memory Visuoconstruction Executive 
function
Verbal fl uency
beta P beta p Beta P Beta P Beta p
-premorbid IQ 0.46 <0.01 0.29 0.02 0.31 <0.01 0.39 <0.01 0.44 <0.01
-YMRS score 0.06 0.47 0.05 0.62 -0.28 <0.01 -0.03 0.77 0.15 0.09
-hospital admissions, n -0.26 <0.01 -0.08 0.48 -0.20 0.04 -0.19 0.06 -0.16 0.11
-Vascular risk factors -0.23 0.01 -0.25 0.02 -0.02 0.86 -0.08 0.42 -0.18 0.06
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Our results show that patients with more vascular risk factors are more cognitively 
impaired than patients with an earlier age of onset. Tamishiro et al. (2008) report a 
increased frequency of white matter hyperintensities in association with late-onset 
bipolar disorder, these changes may lead to cognitive deficits. In elderly patients with 
bipolar disorder there is an increased likelihood of the development of cardiovascular 
diseases, such as hypertension and diabetes. Treatment of these cardiovascular risk 
factors may prevent further cognitive impairment induced by cardiovascular disorders.
In the Netherlands lithium is the first choice mood stabilizer in the treatment of bipolar 
disorder. Every patient in this study used lithium at some moment in the course of their 
treatment. At the time of the study this concerned two thirds of the patient group. 
Although on one hand several studies did not find definite associations between the use 
of lithium and neuropsychological test performance (Rubinsztein et al., 2000; Zubieta et 
al., 2001), lithium had been associated by Pachet and Wisniewski (2003) with poorer test 
performance on test of memory and motor speed. In our study euthymic bipolar patients 
treated with lithium demonstrated cognitive impairment on several cognitive domains, 
but when other risk factors were taken into account lithium was no longer associated 
with poorer cognitive performance. Although drawing causal inferences is precluded 
in a cross-sectional design this would suggest that other factors, associated with both 
cognitive decline and used lithium are responsible.
Although this study had several strong points, such as the inclusion of a comprehensive 
set of risk factors, the selection of patients who were in a euthymic state and controlling 
for confounding effects, it also has his limitations. First, we used a cross-sectional 
design and required patients, some of whom had cognitive problems, to retrospectively 
recall a good deal of information. Clearly, prospective studies on the course of bipolar 
disorder and cognitive impairment are needed to more definitively identify risk factors 
of cognitive decline in bipolar patients. Secondly, our sample size did not allow us to 
analyse the possible differential effect of other mood stabilizers such as  valproic acid and 
carmabazepine and dosage of medication on neuropsychological performance. Cognitive 
impairment has been associated with other mood stabilizers besides lithium and the 
dosage of medication can influence the cognition of bipolar patients, especially those 
with cardiovascular comorbidities. Thirdly, other risk factors such as genetic factors and 
smoking were not addressed. Cognitive impairment may be a trait vulnerability factor 
for bipolar disorder that is present before illness onset. This is suggested by studies that 
report cognitive impairment in unaffected first degree relatives of bipolar patients (Bora 
et al., 2009). 
Discussion
The aim of our study was to investigate whether variables related to the illness in 
euthymic patients with bipolar disorder as well vascular burden, medication and alcohol, 
were associated with different domains of neuropsychological functioning. Previous 
studies have found a number of factors that directly or indirectly may influence cognitive 
functioning in bipolar patients. This is the first study in which we were able to control 
for confounding effects of factors. A comprehensive set of risk indicators was studied in 
relation to their effect on cognitive impairment in a group of elderly euthymic patients. 
The main findings of this study show that more vascular risk factors and a greater number 
of hospital admissions are related to poorer outcome of cognitive functioning. Patients 
who are using lithium have also more impaired cognitive functioning, but this can be 
explained by other risk factors and does not seem due to the exposure to lithium itself.
The causes of cognitive impairment in bipolar disorder are heterogeneous. Age is an 
important risk factor for developing cognitive impairment in elderly people, regardless 
of the presence of bipolar disorder. Our results confirmed that elderly patients showed 
poorer performances on all cognitive measures. With regard to the effect of premorbid 
IQ patients with a higher premorbid IQ performed better on all measures, a possible 
explanation might be indicate that patients with a higher premorbid IQ seem to have 
more compensation strategies for cognitive decline. 
In the Kraepelin distinction between bipolar disorder and schizophrenia (dementia 
praecox), a defining feature of bipolar disorder was the apparent recovery of function. 
However, in recent years, there has been increasing recognition that some degree of 
neurocognitive impairment may persist in patients with bipolar disorder outside of acute 
illness episodes. The number of affective episodes may lead to enduring structural or 
functional changes, in turn leading to cognitive impairment. In our study patients with 
more hospital admissions showed more cognitive impairment. However, unlike other 
studies (Martinez Aran et al., 2004; Thompson et al., 2005) we did not find the number 
of manic or depressive episodes to be significantly related to cognitive impairment. 
One possible explanation is that the retrospective recollection of episode frequency or 
psychotic episodes is often inaccurate among elderly patients, admission to a hospital 
might be a more accurate measure.
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Our data suggest that vascular risk factors related to poorer outcome of cognitive 
functioning, and to a lesser extent some illness characteristics. Awareness and 
management of vascular risk factors and its complications are important to protect 
bipolar patients against cognitive dysfunction. Furthermore, is it also important to reduce 
the negative impact of bipolar disorder on patients cognitive functioning, suggesting 
a more aggressive treatment may help preventing cognitive decline. Relapse should be 
prevented and the clinical course of patients be optimized by clinicians. This means on 
the one hand optimizing the pharmacological treatment, on the other hand providing 
psychoeducation for patients and families (Goldberg and Burdick, 2008). 
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Abstract
Background: Patients with bipolar disorder are at risk to develop cognitive decline in 
the course of their illness. This may affect their ability to monitor and detect their own 
cognitive functioning (anosognosia). The aim of this study was to determine whether 
subjective cognitive complaints were associated with objective neuropsychological 
performance and to consider the role of frontal lobe dysfunction in the awareness of 
cognitive impairment. 
Method: 101 euthymic elderly bipolar patients and 74 healthy controls were assessed 
using a comprehensive neuropsychological battery. The Cognitive Failure Questionnaire 
was used to determine subjective cognitive complaints. 
Results: Elderly bipolar patients had no more subjective cognitive complaints than control 
subjects, whereas they showed less cognitive functioning in several domains. Patients 
with less subjective cognitive complaints showed poorer attentional and executive 
functioning, but the same level of memory performance than patients with many 
cognitive complaints.
Conclusions: Elderly bipolar patients who were not aware of their cognitive deficits 
showed more attentional and executive dysfunction. This might suggest a deficit in 
self-awareness and could influence treatment. Evaluation of cognitive functioning in 
elderly bipolar patients should be part of the treatment program regardless of subjective 
complaints.
Introduction
Poor awareness of functional deficits is common among different patient groups, such 
as patients with schizophrenia and bipolar disorder. Babinski (1914) introduced the term 
‘anosognosia’ to describe the lack of knowledge, awareness or recognition of disease 
observed in patients with hemiplegia attributed to stroke. The term anosognosia, has 
since then been used more generally to refer to the awareness of any neurological or 
neuropsychological deficit. This awareness turns out to be highly vulnerable to frontal 
lobe damage (Prigitano and Schacter, 1991). Unawareness of deficits has been observed 
in a broad range of neuropsychological syndromes and has significant implications for 
patient treatment and management. For instance, lack of awareness in schizophrenia is 
associated with impairment in social and vocational functioning (Cuesta et al, 1996).
Schizophrenia and bipolar disorder are associated with general cognitive impairments 
as a consequence of dysfunctioning of the brain, particularly in the frontal regions. 
Consequently, one might expect that schizophrenic and bipolar patients would exhibit 
disturbed cognition in domains of awareness. A meta-analysis shows that especially 
executive dysfunction contributes to poor insight in patients with psychosis (Cuesta et al, 
1996). Since subjective complaints are negatively correlated with lack of insight (Zanello 
and Huguelet, 2001) one might expect less cognitive complaints in patients with executive 
dysfunction. So far only one study addressed this issue in bipolar patients (Martinez 
et al, 2005), but the results did no support this hypothesis. Adult bipolar patients with 
subjective cognitive complaints had lower scores in domains related to attention, memory 
and executive function compared with the control group, so they seemed well aware of 
their cognitive problems. In our cohort of elderly patients and controls we have a unique 
opportunity to study this phenomenon, because cognitive complaints as well as cognitive 
decline are common among elderly (Comijs et al, 2002; Comijs et al, 2004; Palmer et al, 
2002), and older bipolar patients may show more pronounced cognitive decline compared 
to healthy subjects (Gildengers et al, 2009). 
Knowledge about possible cognitive impairment is an important issue in the treatment 
of bipolar disorder in older persons. Therefore it is important to know if patients can 
reliably report about their cognitive functioning. As a consequence, the aim of this study 
was to assess the association between subjective cognitive complaints and objective 
neuropsychological performance in elderly bipolar patients and controls. Another aim 
was to consider the role of executive dysfunction in the awareness problem. We expect 
that elderly patients with bipolar disorder have more difficulty to evaluate their cognition 
Chapter   5
74
Self-reported cognitive complaints in elderly bipolar patients
75
adequately. We hypothesize (1) that patients with a bipolar disorder with less cognitive 
complaints show worse cognitive functioning than patients with subjective complaints 
and normal controls and (2) that this lesser awareness of cognitive deficits is associated 
with more executive dysfunction.
Methods
Sample
The study group included 101 older patients (>60 years) with bipolar-I and bipolar-II 
disorder, who were currently euthymic. Since most of the bipolar patients reside in the 
community, we focused on outpatients. Patients were recruited from outpatient clinics 
in four regions in the Netherlands. With help form the Dutch bipolar patient association 
(VMDB, Association for Manic Depressives and their Relatives) additional patients were 
recruited. Extensive care was taken to exclude patients with current mood symptoms, since 
these symptoms may influence cognition. Eligible subjects were reported to be euthymic 
for at least three weeks by their psychiatrist. Excluded were patients with a primary 
diagnosis of alcohol dependence or substance abuse and patients with dementia. Lithium 
(44% of the patients), valproic acid and carbamazepine were the typical medications for 
the remitted patient in this study. Among the 101 patients only 7 subjects (7%) did not use 
any medication. The control group consisted of 74 persons who had no current or lifetime 
history of psychiatric or addiction disorders or recent memory complaints. The control 
group was recruited from community centres for elderly people and local newspapers. 
The study was approved by the institutional review board and written informed consent 
was obtained by all subjects.
Measurements
Diagnostic and psychopathological assessment
Clinical diagnosis of bipolar disorder was reached using the Structured Clinical Interview 
for DSM-IV (SCID) (First et al, 1996). Current depressive symptoms were assessed using 
the Centre for Epidemiologic Studies Depression Scale (CES-D) (Radloff, 1970) and current 
mania symptoms with the Young Mania Rating Scale (YMRS) (Young et al, 1978). Illness 
characteristics such as age of onset and medication were derived from patient interviews 
and hospital medical records. Premorbid intelligence was estimated using the Dutch 
Reading Test for Adults (NLV), the Dutch version of the New Adult Reading Test (NART) 
(Nelson et al, 1978). The Mini Mental State Examination (MMSE) (Folstein et al, 1978) was 
used to provide an overall assessment of cognitive functioning. 
Self-reported cognitive problems
The Cognitive Failures Questionnaire (CFQ) was developed by Broadbent et al (1982) and 
translated into Dutch by Merkelbach and Ponds (1998). The CFQ contains 25 items and 
measures self-reported failures in perception, memory and motor functions. Respondents 
were asked to indicate the frequency with which they experienced common types 
of cognitive mistakes (e.g., misplacing one’s keys, absent-mindedness, or forgetting 
appointments), using a five-point scale ranging from “Never” to “Very often”. The time 
period of focus for the respondent was the past 6 months. Because no normative values 
have been established for cut-off points to differentiate between many and few complaints 
we used mean CFQ total scores. Those patients who reported an average score beneath 
the mean were included in the group ”few cognitive complaints”, whereas those with a 
average score above the mean were included in the group “many cognitive complaints”.
 
Neuropsychological test battery
All subjects completed a comprehensive battery of neuropsychological tests grouped into 
five cognitive domains. The five domains are:
a)   Attention: Digit Span subtest of the Wechsler Adult Intelligence Scale (WAIS-III) 
(Wechsler, 1981) Trail Making Test Part A(Reitan, 1958),The Amsterdam Short Term 
Memory Test (ASTM) (Schmand and Lindeboom, 2005).
b)   Learning and memory: The 10 Words Test, a modified version of the Auditory Verbal 
Learning Test (Rey, 1964).
c)   Visuo constructional ability: Figure Copying subtest of the Amsterdam Dementia 
Screening Test (ADS6) (Lindeboom and Jonker, 1989), and Clock Drawing (Shulman et 
al, 1993).
d)   Executive functioning: Trail Making Test Part B (Reitan, 1958), Modified version of 
the Stroop Color Word Test (Golden, 1978) , Mazes (1 to 4) subtest of the Wechsler 
Intelligence Scale for Children (WISC) (Wechsler, 1976), and the Rule Shift Cards subtest 
of the Behavorial Assessment of the Dysexecutive Syndrome (BADS) (Wilson et al, 
1996).
e)   Verbal fluency: Control Oral Word Association Test (COWAT) (Benton, 1976), Animal and 
Occupation Naming subtest of the Groningen Intelligence Test (GIT) (Luteijn and van 
der Ploeg, 1983).
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Statistical analyses
Composite scores for each neurocognitive domain were calculated by converting 
the subject’s raw scores to standardized z-scores. The z-scores were then summed in 
each domain to provide a single score. A higher score indicated better neurocognitive 
performance. 
The three groups (bipolar patients with many complaints, with less cognitive complaints 
and a healthy comparison group) were compared regarding clinical and sociodemographic 
characteristics using ANOVA and χ2 tests. To test the hypothesis that bipolar patients 
with few subjective cognitive complaints have worse cognitive functioning compared 
to persons with many cognitive complaints one-way ANOVA was performed. To test the 
hypothesis that a lesser awareness of cognitive deficits is especially associated with 
executive dysfunction, we performed multivariate logistic regression analyses adjusted 
for age and premorbid intelligence. All analysis were performed with SPSS version 15.0.
Results
Demographic and clinical characteristics
58% of the bipolar patients (n=59) reported many cognitive complaints. There is no 
difference in mean CFQ total score between the patients group (M=45.38) and the 
comparison subjects (M=49.22; t-test p=0.40). Patients with either few or many 
cognitive complaints were compared with healthy controls with regard to clinical and 
demographic characteristics (Table 1). Bipolar patients with less memory complaints had 
a lower premorbid intelligence than the patients with many memory complaints and the 
comparison group, but did not differ on educational level. Care was taken to make sure 
that patients included were euthymic. The very low scores on both the YMRS and CES-D 
bear testimony to this. However, even with the very narrow range of symptoms that the 
strict inclusion criteria allowed, bipolar patients reported more manic symptoms than 
the comparison group. Bipolar patients with less cognitive complaints had a lower MMSE 
score, which indicates that these patients are overall more cognitively impaired than both 
other groups. Patients with many cognitive complaints were younger than patients with 
few complaints and normal comparison group. 
Cognitive functioning
Both patient groups differed from the controls on all cognitive measures, but patients 
with few cognitive complaints had worse cognitive functioning than patients with many 
cognitive complaints (Table 1). Patients with few cognitive complaints scored lower on 
attention, visuo-construction and executive function compared to patients with many 
cognitive complaints. Both groups did not differ on memory and verbal fluency. 
In order to identify which cognitive domains were associated with cognitive complaints 
in the patient group, we performed logistic regression analyses. Less functioning in 
the domain of attention, visuoconstruction, executive function and verbal fluency was 
associated with few cognitive complaints (Table 2, p. 78). However, after controlling for 
age and premorbid intelligence only worse executive function was associated with few 
subjective cognitive complaints (OR 1.28, 95% CI 1.03 to 1.59).
Table 1.  Sociodemographic and illness characteristics and neuropsychological performance in bipolar patients with 
many and with less cognitive complaints and comparison group
With many 
cognitive 
complaints
(n=59)
With less 
cognitive 
complaints                
(n=42)          
Comparison 
group  (n=76)           F      p  
Between 
group 
contrast
       
Age, years (SD) 67.76 (6.3) 71.83 (7.9) 71.76 (7.9) 5.10 <0.01 A<B,C
Men, n (%) 30 (51%) 20 (48%) 20 (27.0%) A,B>C
Education 5.29 (1.30) 4.71 (1.8) 5.30 (1.2) 2.46 0.09
Estimated premorbid IQ (SD) 108.78 (11.7) 105.43 (16.9) 111.89 (9.1) 3.21 0.04 B<A,C
Age at onset, years (SD) 41.29 (13.4) 43.48 (17.2) 0.59 0.44
Number of admissions, n (SD) 2.96 (3.7) 3.60 (3.4) 0.07 0.79
Number of manic episodes 
(SD)
3.78 (3.6) 3.56 (2.8) 0.07 0.79
Duration of illness, years (SD) 26.47 (12.5) 28.36 (14.7) 0.13 0.72
MMSE, total score (SD) 28.00 (4.1) 27.43 (2.1) 29.05 (1.1) 5.17 <0.01 B<A,C
CES-D, total score (SD) 13.49 (8.2) 9.40 (7.4) 11.55 (6.1) 0.91 0.40
YMRS, total score (SD) 1.19 (1.8) 0.83 (1.4) 0.15 (0.4) 8.68 <0.01 A, B>C
CFQ, total score (SD) 62.78 (7.93) 40.81 (6.61) 49.22 (15.77) 45.46 <0.01 A<C<B
Attention -0.40 (2.4) -2.06 (5.0) 1.89 (2.4) 22.10 <0.01 B<A<C
Memory -0.53 (2.2) -1.25 (2.9) 1.37 (2.1) 21.94 <0.01 A, B<C
Visuo-construction 0.31 (1.3) -0.73 (2.1) 0.37 (1.5) 8.32 <0.01 B<A,C
Executive function 0.13 (2.2) -1.51 (3.4) 0.89 (1.9) 15.33 <0.01 B<A<C
Verbal fl uency -0.52 (2.1) -1.31 (2.7) 1.29 (2.2) 27.07 <0.01 A, B< C
MMSE: Mini-Mental State Examination; CES-D : Center for Epidemiologic Studies Depression Scale;YMRS : 
Young Mania Rating Scale; CFQ : Cognitive Failure Questionaire.
A=with many cognitive complaints B=with less cognitive complaints C= comparison group
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Discussion
Nearly 60% of elderly bipolar patients who were euthymic had considerable subjective 
cognitive complaints. With respect to normal controls bipolar elderly patients had the 
same number of cognitive complaints, but they showed worse cognitive deficits. It appears 
to be more difficult for elderly bipolar patients to evaluate their cognition adequately 
compared with normal controls, just because of their cognitive problems. In our study we 
could confirm the hypothesis that bipolar elderly patients with less subjective cognitive 
complaints had worse cognitive functioning. Furthermore, a lesser awareness of cognitive 
deficits was associated with especially executive dysfunction. 
Our findings add to the literature that has previously observed frontal dysfunction in 
euthymic bipolar patients (Gunning-Dixon et al, 2008). This suggests that perhaps a 
poorer performance in measures that involve frontal lobes is associated with the absence 
of insight into cognitive dysfunction and, most likely, with illness awareness. Pini et 
al. (2001) found that patients with bipolar disorder did not differ in deficits in insight 
from patients with schizophrenia. Comprehensive research showed that many patients 
suffering from schizophrenia have poor insight. Less awareness of different aspects of 
mental disorder is associated with poorer psychosocial functioning in these patients, a 
poorer course of illness and a lack of adherence to treatment.
Tabel 2.  Results logistic regression analyses for the association between cognitive 
domains and cognitive complaints in bipolar patients
Cognitive domain OR 95% CI p
Attention
- adjusted for age and PIQ*
1.16
1.13
1.02 to 1.32
0.96 to 1.34
0.03
0.14
Memory
- adjusted for age and PIQ
1.13
1.06
0.96 to 1.34
0.87 to 1.29
0.14 
0.55
Visuo-construction
- adjusted for age and PIQ
1.45
1.32
1.08 to 1.94
0.94 to 1.87
0.02
0.11
Executive function
- adjusted for age and PIQ
1.30
1.28
1.09 to 1.55
1.03 to 1.59
<0.01
0.02
Verbal fl uency
- adjusted for age and PIQ
1.17
1.06
0.97 to 1.40
0.84 to 1.35
0.10
0.61
* PIQ is premorbid IQ
 
Another interesting finding of our study was that age did not have influence on the 
subjective experience of cognitive dysfunction. Contrary to our results Burdick et al 
(2005) observed that older patients reported more cognitive complaints than younger 
patients. The present results are in line with Mendes et al (2008) who indicate that 
subjective memory complaints in bipolar patients do not increase along the lifespan. An 
explanation could be that young and old individuals might have different reasons to have 
a poor impression of their own memory abilities. Younger individuals may attribute their 
complaints to potentially reversible causes, such as stressful life events and concentration 
problems, while older individuals could attribute their complaints to a group of less 
reversible causes, such as aging.
Although this study had several strong points, such as the inclusion of a relatively large 
patient and comparison group and the careful selection of patients who were in a 
euthymic state, it also has a limitation. The present study required individuals, with some 
of those having memory and cognitive problems, to retrospectively recall a good deal of 
information. Direct assessment of everyday functions and diary methods may be more 
powerful instruments to identify cognitive problems and how frequent they occur (Depp 
et al, 2009).
The present findings indicate objective signs of cognitive dysfunction in a majority 
of elderly bipolar outpatients, and that there is no robust correspondence between 
subjective and objective measures of neuropsychological impairment. Patients with 
worse cognitive functioning, especially executive dysfunction, have a lesser awareness 
of cognitive deficits. This absence of subjective complaints in the presence of cognitive 
dysfunction may contribute to treatment nonadherence. Our results suggest that 
bipolar patients with and without complaints should be objectively evaluated at least 
by a brief neuropsychological assessment, since probably some of the patients who do 
not complain show some kind of real cognitive impairment. Cognitive status of bipolar 
patients should be an important issue in the treatment of bipolar patients regardless of 
subjective complaints.
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Abstract
Background: Older individuals with bipolar disorder may exhibit greater cognitive decline 
over time compared to mentally healthy elderly. We aimed to investigate neurocognitive 
performance in bipolar disorder over a period of two years.
Method: A comprehensive neuropsychological testbattery was applied at baseline and 
two years later to 64 euthymic bipolar elderly outpatients with bipolar disorder (mean 
age=68.35, range 60-90 years) and to a demographically matched sample of 42 healthy 
elderly. General Linear Model was used to measure changes over time for the two groups. 
The impact of baseline illness characteristics on intra-individual change in neurocognitive 
performance within the bipolar group was studied by using logistic regression analysis.
Results: At baseline and at follow up bipolar patients performed worse on all neurocognitive 
measures compared to the healthy elderly. However, there was no significant group-by-
time interaction between bipolar patients and the comparison group. 
Conclusions: Although older bipolar patients have worse cognitive function than normal 
controls they did not have  greater cognitive decline over a period of two years.
Introduction
Findings from epidemiological studies suggest that depression or depressive symptoms 
may be a risk factor for development of cognitive decline or dementia (Kessing and 
Andersen, 2004; Jorm 2000; Thomas and O’Brien 2008). There is also some evidence 
that individuals with bipolar disorder develop dementia at a higher rate than expected 
compared to healthy subjects (Dhingra and Rabins, 1991). Other studies however, suggest 
that lithium treatment could reduce the risk of Alzheimer disease in patients with bipolar 
disorder (Kessing et al, 2010). A large number of cross-sectional studies have revealed 
cognitive impairment in patients with bipolar disorder of any age, even in euthymic 
state. These cognitive impairments are now thought to be an integral part of the bipolar 
disorder (Quraishi and Frangou, 2002; Robinson and Ferrier, 2006). Recent studies have 
found that elderly bipolar patients have more cognitive and functional impairment than 
younger patients (Depp et al, 2005). This suggests that cognitive impairment manifests 
itself in early life and middle age, but that a significant decline may not be apparent until 
older age.
Only a few studies have been published on the course of cognitive function in elderly 
patients with bipolar disorder. Dhingra and Rabins (1991) followed patients over the age 
of 60 for 5-7 years after they were hospitalized for mania. Eight of 25 (32%) patients had 
a decline in Mini-Mental State Examination scores to below 24 points and less. Depp et 
al (2008) examined 35 outpatients with bipolar disorder (mean age 58) with a battery 
of neuropsychological tests from one to 3 years after baseline. They found that patients 
with bipolar disorder did not differ from normal comparison subjects or patients with 
schizophrenia in mean trajectories of change, but intra-individual variability was more 
pronounced over time. 
Recently Gildengers et al (2009) examined 33 euthymic patients over the age of 50 (mean 
age 69.7) at baseline and longitudinally over three years with the Dementia Rating Scale 
(DRS). Older bipolar patients showed more cognitive dysfunction and more rapid cognitive 
decline compared to a healthy comparison group. The primary aim of the present study 
was to compare a large group of patients (62), who were euthymic at the time of testing, 
with a matched sample of healthy elderly using a comprehensive neuropsychological 
battery at baseline and at a two year follow up. A comprehensive neuropsychological 
assessment has a greater sensitivity to detect cognitive impairment than screening 
instruments and may show which cognitive domains are more sensitive to decline. 
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We controlled for residual affective symptoms at both time points, because even small 
degrees of residual manic or depressive symptoms may have a negative impact in 
cognition.
We first examined baseline differences between the bipolar group and the comparison 
group. We then compared the changes in the different neurocognitive domains over two 
time points across study groups. We hypothesized that patients with bipolar disorder 
would exhibit more cognitive deficits with respect to a mental healthy comparison group, 
and that they would exhibit a faster decline at follow up. Finally, we tried to establish 
baseline clinical characteristics that could predict neurocognitive change in the bipolar 
group.
Method
Subjects
As previously described elderly patients (>60 years) with bipolar-I and bipolar-II disorder, 
who were currently euthymic, were recruited from outpatient clinics in four regions in 
the Netherlands (Schouws et al, 2009) . With the help from the Dutch bipolar patient 
association (VMDB, Association for Manic Depressives and their Relatives) extra patients 
were recruited. Extensive care was taken to exclude patients with current mood symptoms, 
which could influence cognition. Eligible subjects were reported to be euthymic for at 
least three weeks by their psychiatrist. Excluded were patients with a primary diagnosis 
of alcohol dependence or substance abuse and patients with dementia. The control group 
consisted of persons who had no current or lifetime history of psychiatric or addiction 
disorders or recent memory complaints. The control group was recruited from community 
centres for elderly people and local newspapers. In figure 1 a flow diagram shows inclusion 
and attrition in the study. The study was approved by the institutional review board and 
written informed consent was obtained by all subjects.
At follow-up after two years all subjects were outpatients in remission. The original sample 
consisted of 119 bipolar patients and 78 healthy controls. Thirty two subjects (12 patients 
and 20 controls) were not tested due to a limited budget of the study, compared to the 
study sample these subjects had the same sociodemographic and clinical characteristics. 
At follow up two year later we tested 65 patients, all clinically euthymic for at least three 
weeks, and 42 comparison subjects.
Compared with the persons lost to follow up, the longitudinal sample (completers) did 
not differ on age and gender. Subjects in the longitudinal sample had a significantly 
Baseline
After two years
Biopolar
patients
N=119
N=65 N=42
Healthy
controls
N=78
Refused N=14
Died N=4
Could not be
reached N=7
Not euthymic
N=10
Meidcal illness
N=7
Not contacted
due to limited
budget N=12
Refused N=1
Died N=1
Could not be
reached N=12
Meidcal illness
N=2
Not contacted
due to limited
budget N=20
Figure 1. Flow chart follow up bipolar patients and controls after two years
higher premorbid IQ than persons lost to follow up (p<0.05). Table 1 describes the results 
of the neuropsychological measurements for the two samples at two time points. The 
longitudinal sample performed better on the learning condition of the 10 Word test and 
Occupation naming compared to the subjects lost to follow up at T1.
Measurements
Clinical measures
At baseline (T1) the clinical diagnosis of bipolar disorder was reached using the Structured 
Clinical Interview for DSM-IV (SCID) (First et al, 1996). Illness characteristics such as age 
of onset and medication were derived from patient interviews and hospital medical 
records. Premorbid intelligence was estimated using the Dutch Reading Test for Adults 
(NLV), the Dutch version of the New Adult Reading Test (NART) (Nelson and O’Connell, 
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1978). At baseline (T1) and follow-up (T2) two years later, current depressive symptoms 
were assessed using the Centre for Epidemiologic Studies Depression Scale (CES-D) 
(Radloff, 1976) and current mania symptoms with the Young Mania Rating Scale (YMRS) 
(Young et al, 1978). The Mini Mental State Examination (MMSE) (Folstein, 1975) was used 
to provide an overall assessment of cognitive functioning. For this study a cerebrovascular 
risk score (range 0-2; 0=zero risk factors, 1=one risk factor = more than one risk factor) 
was determined as follows: respondents were asked whether they currently or previously 
had any of the following chronic diseases or disease events: disease of circulatory system 
(myocardial infarction, angina pectoris, heart failure, cardiac dysrhytmia), hypertension, 
history of ischemic attack or stroke and diabetes.  Answers were coded as either ‘yes’ or 
‘no’ for each of these diseases.
Neuropsychological test battery
All subjects completed at T1 and T2 a comprehensive battery of neuropsychological tests 
grouped into four cognitive domains:
a)   Attention: Digit Span subtest of the Wechsler Adult Intelligence Scale (WAIS-III) 
(Wechsler, 1981), Trail Making Test part A (Reitan, 1958), The Amsterdam Short Term 
Memory Test (ASTM) (Schmand and Lindeboom, 2005).
b)   Learning and memory: The 10 Words Test, a modified version of the Auditory Verbal 
Learning Test (Rey, 1964)
c)   Executive functioning: Trail Making Test part B (Reitan, 1958), Modified version of 
the Stroop Color Word Test (Golden, 1978) , Mazes (1 to 4)  subtest of the  Wechsler 
Intelligence Scale for Children (WISC) (Wechsler, 1976).
d)   Verbal fluency: Control Oral Word Association Test (COWAT) (Benton, 1976), Animal and 
Occupation Naming  subtest of the Groningen Intelligence Test (GIT) (Luteijn and van 
der Ploeg, 1983)
Statistical analyses
We compared bipolar patients and comparison subjects on each of the demographic and 
clinical variables using t-tests for continuous measures and chi-square tests for categorial 
ones at baseline and follow up. Distributions of the continuous measures were examined 
prior to analyses. Longitudinal mood symptoms and MMSE scores of bipolar patients 
and comparison subjects at baseline and follow up were compared using multivariate 
analyses of variance (MANOVA). 
Composite scores for each neurocognitive domain were calculated by converting the 
subject’s raw scores to standardized z scores. The z scores were then summed in each 
domain to provide a single score. A higher score indicated better neurocognitive 
performances.
Table 1.  Sociodemographic and clinical characteristics and neuropsychological performance for completers and 
persons lost to follow up at baseline: Mean (s.d.)
Measure Completers 
(N=107)
Persons lost to 
follow-up (N=90)
Staristical 
analysis
F
p
Age, years 69.98 (7.3) 72.13 (7.7) 0.13 0.05
Men, n (%) 42 (39%) 37 (41%)
Estimated premorbid IQ 111.10 (11.3) 106.97 (13.3) 1.81 0.02
MMSE 27.93 (3.1) 27.78 (3.6) 0.01 0.81
CES-D, total score 9.16 (7.2) 9.23 (6.0) 2.64 0.11
YMRS, total score 0.66 (1.4) 0.71 (1.4) 0.03 0.86
Attention
Digits forrwad 5.45 (1.1) 5.37 (0.9) 0.16 0.69
Digits backward 4.24 (1.1) 4.20 (1.1) 0.97 0.32
Trail making test part A, s 59.09 (35.9) 71.63 (57.2) 2.89 0.09
ASTM (item 1 to 10) 28.38 (1.7) 27.61 (4.6) 2.34 0.13
Declarative memory
10 words test
Learing (trials 1 to 5) 32.63 (7.0) 31.89 (8.5) 6.53 0.01
retention 5.50 (2.4) 5.28 (2.4) 2.26 0.13
recogntion 18.85 (1.3) 18.48 (2.2) 0.47 0.49
Ececutive function
Stroop Color Word test a, s 57.71 (27.9) 58.58 (28.2) 2.69 0.10
Trail making test part B, s 161.36 (109.6) 163.61 (116.6) 1.53 0.21
Mazes (item 1 to 4)
Planning time 145.47 (101.9) 175.89 (137.4) 2.37 0.12
Lamguage function
Letters D-A-T 29.83 (11.6) 26.97 (13.5) 1.29 0.26
Animal naming 21.06 (6.3) 19.29 (5.9) 1.52 0.22
Occupation naming 15.72 (5.2) 14.72 (5.8) 4.69 0.03
MMSE, Mini-Mental State Examination; CES-D, Center for Epidemiologic Studies Depression Scale;YMRS, 
Young Mania Rating Scale; ASTM, Amsterdam Short Term Memory Test
a This is a short form consisting of reading the fi rst 4 lines
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Results
Demographic and baseline clinical and neuropsychological comparisons
Baseline characteristics of the 65 participants with bipolar disorder and 42 control subjects 
are displayed in Table 2. There were no significant differences in premorbid IQ, education 
or vascular risk factors. Subjects with bipolar disorder were significantly younger than 
controls and included more males (χ2=9.33, p<0.01). Lithium (72% of the patients), valproid 
acid and carbamazepine were the typical medications for the remitted patient in this 
study. Among the 65 patients only 2 subjects (3%) did not use any medication.
Although the bipolar group had significantly higher YMRS scores than the comparison 
group on both measurements, the scores were below cut off point at each time point and 
the level of mood symptoms among bipolar patients was very low. The bipolar group did 
not differ on CES-D scores from the comparison group on T1 and T2, but both the patient 
group and the comparison group had higher CES-D scores after two years. The scores 
however indicated low depressive symptoms at both time points.
Repeated measures analyses of Covariance (MANCOVA) were employed to analyse the 
longitudinal changes on neuropsychological test of the two groups . Effects of group, time, 
and group-by-time interactions were examined. A significant group-by-time interaction 
would indicate that the change in cognitive functions over time differed between the 
groups. Effect sizes were calculated by means of η2 (η2<0.15 indicate small to medium 
effects, η2>0.14 indicate large effects (Cohen, 1988)).
In order to examine interindividual differences in bipolar patients with respect to 
cognitive decline in a period of two years, we dichotomized the difference scores from the 
domain scores in 1=highest two tertiles representing no cognitive decline and 0= lowest 
tertile representing  relevant cognitive decline. To test whether demographic and illness 
characteristics were associated with cognitive decline first a univariate logistic regression 
analysis was carried out. We then performed multivariate logistic regression analyses 
on the variables which influenced cognitive changes, adjusted for age and premorbid 
intelligence.
Two-tailed tests were used for all analyses and statistical significance was defined as 
p<0.05. Statistics were processed with the SPSS Version 15.0 for Windows.
Table 2.  Sociodemographic and clinical characteristics in patients with bipolar disorder (n=65) and healthy 
comparison subjects (n=42)
Bipolars (n=65) Healthy subjects (n=42) T P
- Age (M, SD) 68.35 (6.5) 72.75 (8.0) -2.97 <0.01
- Premorbid IQ (M,SD) 110.71 (12.3) 111.73 (9.4) -0.45 0.65
- Education (M,SD) 5.09 (1,6) 5.28 (1.2) -0.59 0.56
- Sex: male (N, %) 31 (47.7%) 11 (26.2%)
- Vascular risk factors (M, SD) 0,45 (0.7) 0.70 (0.8) -1.72 0.07
- Hospital admissions  (M,SD) 3.86 (3.6)
- Depressive episodes (M, SD) 4.39 (3,3)
- Manic episodes, (M, SD) 2.96 (1.7)
- Psychotic episode (N, %) 45 (70%)
- Months eythymic (M, SD) 50,98 (58.0)
- Duration illness (M, SD) 29,29 (14.4)
- Age at onset (M, SD) 39.06 (15,1)
- Age of fi rst psychiatric 
treatment (M, SD)
43.06 (15.6)
T1 T2 T1 T2
- MMSE 28.60 (1.2) 28.28 (1.6) 29.05 (1.9) 29.20 (1.1) 16.9 a <0.01
- YMRS 1.06 (1.7) 1.06 (1.1) 0.10 (0.4) 0.18 (0.5) 20.3 a <0.01
- CESD 9.86 (7.5) 12.51 (5.5) 8.53 (6.4) 11.38 (5.2) 3.9 a 0.60
a F Repeated-measures MANOVA main effects of groups (tests of between-subject effects)
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Rate of cognitive decline in cognitive domains
Our hypothesis was that patients with bipolar disorder would exhibit a faster rate of 
decline  in all cognitive domains compared to a healthy comparison group, and that they 
would exhibit a faster decline in several cognitive domains  at follow up. Table 4 shows 
the mean (SD) of the z-scores on the different cognitive domains at T1 and T2. In order 
to compare changes over time for each cognitive domain a group by time repeated-
measures MANCOVA was performed controlling for the covariates (premorbid IQ and age). 
Table 3 shows the mean (SD) of the raw neurocognitive scores at T1 and T2. As in our former 
study with the original, large sample (Schouws et al. 2009), the bipolar patients did less 
well on all cognitive tests when compared to the healthy subjects (all tests p<0.05) at T1. 
Similar results were observed at T2.
Table 3.  Neuropsychological performance at baseline (T1) and 2-year endpoint (T2) for all participants: Mean (SD)
Measure Bipolar patients  
(n=65)
T1 T2
Healthy controls 
(n=42)
T1 T2
Attention
Digits forrwad 5.26 (1.1) 5.46 (1.2) 5.74 (1.0) 5.76 (1.1)
Digits backward 3.98 (1.0) 3.83 (0.9) 4.64 (1.1) 4.36 (1.1)
Trail making test part A, s 66.75 (41.8) 64.86 (41.5) 47.24 (19.3) 52.45 (27.3)
ASTM (item 1 to 10) 28.02 (2.0) 27.65 (2.4) 28.98 (1.0) 28.83 (1.2)
Declarative memory
10 words test
Learing (trials 1 to 5) 30.21 (6.9) 30.58 (7.6) 36.38 (5.4) 33.90 (6.9)
Retention 4.78 (2.4) 4.82 (2.2) 6.60 (1.8) 6.17 (1.9)
Recogntion 18.54 (1.5) 17.77 (3.8) 19.33 (0.9) 18.83 (1.4)
Ececutive function
Stroop Color Word test a, s 65.86 (31.3) 61.97 (31.1) 48.31 (14.7) 49.07 (17.3)
Trail making test part B, s 188.82 (124.2) 196.17 (131.3) 118.86 (62.6) 139.14 (101.5)
Mazes (item 1 to 4)
Planning time 160.89 (107.9) 176.74 (140.1) 121.60 (87.8) 129.83 (104.1)
Lamguage function
Letters D-A-T 25.78 (10.3) 27.18 (12.0) 36.09 (10.9) 33.50 (13.5)
Animal naming 19.48 (5.2) 18.88 (5.2) 23.50 (6.9) 23.02 (5.9)
Occupation naming 14.91 (5.2) 13.66 (4.9) 13.98 (4.9) 16.76 (4.9)
ASTM, Amsterdam Short Term Memory Test
a This is a short form consisting of reading the fi rst 4 lines
MANCOVA revealed main effects of groups for all cognitive domains (attention, memory, 
executive function and language function), but no significant interactions were found.
Predicting cognitive decline
To test whether demographic and illness characteristics were associated with cognitive 
decline within the group of bipolar patients first a univariate logistic regression 
analysis was carried out. This showed that the severity of manic symptoms at baseline 
predicted decline in the domain of memory (OR=1.40, 95% CI 1.02 to 1.92) and number 
of hospitalizations predicted decline in language function (OR=1.17, 95% CI 1.01 to 1.36). 
Multivariate logistic regression analysis controlling for age and premorbid intelligence 
showed that more manic symptoms were significantly associated with a greater 
decline on memory (OR=1.38, 95% CI 1.01 to 1.90). The association between number of 
hospitalizations and language function was no longer significant.
Table 4.  Cognitive domain (z scores) at baseline (T1) and at 2-year endpoint (T2) for all participants: Mean (SD) 
Bipolar  
patients 
(n=65)
Healthy 
controls 
(n=42)
T1 T2 T1 T2 F p 2
Attention -0.83 (2.9) -0.63 (3.1) 1.31 (2.2) 1.11 (2.3) 22.15a <0.01 0.18
Time X group 0.27 0.60 <0.01
Declarative 
memory
-0.87 (2.7)  -0.54 (2.5) 0.84 (1.8) 1.35 (1.7) 34.44a <0.01 0.25
Time X group 3.38 0.07 0.03
Executive function -0.53 (2.6) -0.47 (2.7) 0.96 (1.6) 0.79 (1.9) 29.90a <0.01 0.23
Time X group 0.13 0.72  <0.01
Language 
function
-0.76 (2.2)   -0.70 (2.5) 1.17 (2.4) 1.09 (2.5) 35.36a <0.01 0.25
Time X group 0.06 0.80 <0.01
a  Repeated-measures MANCOVA main effects of groups (tests of between-subject effects)
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Discussion
Older adults with bipolar disorder exhibit worse cognitive functioning compared to 
healthy controls, but no greater cognitive decline over a period of two years. None of 
the demographic or illness characteristics were associated with cognitive decline in 
the domains of attention, executive and language functioning. Only manic symptoms 
predicted cognitive decline in memory. 
Our findings are in line with Depp and colleagues (2005) but differ from those of Dhingra 
and Rabins (1991) and Gildengers and colleagues (2009). As in our study, subjects with a 
bipolar disorder studied by Depp et al (2005) exhibited no change in cognitive performance 
between baseline and follow up. However, in contrast with our study the euthymic state of 
patients was not established, which may have influenced the results. The bipolar patients 
studied by Gildengers et al. (2009) and Dhingra and Rabins (1991) exhibited significant 
cognitive decline in contrast to our results. In the study by Dhingra and Rabins (1991) no 
control group was included, so it is difficult to detect the effect of other variables such 
as aging. The group studied by Gildengers et al.(2009) was relatively small and almost a 
third of them had a history of alcohol abuse, which may have negatively influenced the 
results. Furthermore, there was no measure to control for the effect of mood symptoms 
to check if a change in cognitive impairment were corresponding with changes in mood 
symptoms. It seems likely that the group studied by Gildengers et al.(2009) was more 
impaired and more prone to detoriation.
In the present study lithium was not associated with cognitive decline over a period of 
two years. It has been suggested that lithium may have neuroprotective abilities and may 
reduce the risk of developing dementia (Kessing et al, 2010). In this study more than two 
thirds of the patient group used lithium, which may have compensated for a possible 
cognitive decline. In the study by Gildengers et al. (2009) only a third of the patients used 
lithium. The finding that bipolar patients do not have a faster rate of cognitive decline 
may be due to the shorter interval between baseline and follow up than in the study 
of Dhingra and Rabins (1991). May be more time is necessary to detect a faster rate of 
cognitive decline in patients with bipolar disorder.
Although our naturalistic study had several strong points, such as the inclusion of a 
relatively large group of patients, using a comprehensive battery of neuropsychological 
tests and a careful selection of patients who were in a euthymic state at both time points, 
it also has some limitations. By nature of the design of this study and due to old age 
not all subjects completed follow up. Comparing the baseline characteristics of persons 
lost to follow up with those of the longitudinal sample (completers) we found that the 
persons who were included in the longitudinal analyses performed better on the learning 
condition of the memory test and one of the verbal fluency tests. Ten patients were 
excluded from the follow up because they were not euthymic. These persons may have 
been the most severely ill, and may possible have had more cognitive decline. Furthermore, 
although efforts were made to recruit a representative bipolar sample, this was not  a 
catchment study so our euthymic outpatients and controls are a convenience sample. 
They may belong to a better outcome subgroup, and in that case, results would only apply 
to that subset of patients with bipolar disorder.
Prospective studies following bipolar samples within the broad range of the spectrum 
are awaited with detailed description of drug treatment and clinical features. A clinical 
issue to be solved is if cognitive impairment in bipolar disorder might be associated to 
relapse and poor clinical outcome. An important implication of our study is that although 
cognitive impairment is a part of elderly bipolar disorder is seems to be rather consistent 
in time for at least a subgroup of patients. 
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This chapter presents the main findings of the research questions formulated in Chapter 1, 
followed by a discussion of methodological issues and conceptual considerations, clinical 
implications and suggestions for future research. 
Main findings
1.  Do older patients with an early onset Bipolar-I disorder who are in a euthymic state exhibit 
cognitive deficits compared with normal elderly people? (Question 1, Chapter 2)
Neuropsychological deficits are evident in euthymic bipolar patients of different ages. 
There is limited information regarding the cognitive functioning of elderly bipolar 
patients. In our pilot study 15 elderly early-onset Bipolar-I patients were impaired across 
a range of cognitive functions, including selective attention and verbal fluency (both 
aspects of executive functioning), verbal memory and mental effort compared with 15 
matched comparison subjects without mood disorder or memory complaints. 
2.  Do older patients with bipolar disorder who are in a euthymic state exhibit cognitive 
deficits compared with normal elderly people? (Question 2, Chapter 3)
Following the pilot study, the next step was to investigate a larger group of 119 patients 
with early- and late-onset Bipolar-I and Bipolar-II disorders and 78 controls. Bipolar patients 
scored lower on psychomotor performance, mental effort, attention, verbal memory, 
executive function and verbal fluency. They did not differ on visuoconstruction. There 
was no difference between Bipolar I and Bipolar II patients. Our findings are consistent 
with a growing body of evidence that bipolar patients also experience cognitive deficits 
during mood-stable episodes, and that these deficits affect a range of cognitive domains, 
including attention, executive functioning, verbal declarative memory and psychomotor 
speed (e.g. Thompson et al., 2005). This may suggest a trait-related dysregulation, causing 
bipolar patients to have cognitive deficits even when they are euthymic, and regardless 
of their age.
3.  Do late-onset bipolar patients show more cognitive decline than early-onset bipolar 
patients? (Question 3, Chapter 3)
Late-onset disorders are often associated with organic cerebral disturbances that may 
lead to cognitive decline (van Gerpen et al., 1998). We studied early-onset (<40 years) 
bipolar patients (N=59) and late-onset bipolar patients (N=60). Both bipolar groups 
demonstrated substantial neuropsychological impairments when compared with the 
comparison group (N=78). Late-onset bipolar patients were more impaired with regard 
to psychomotor performance, word fluency and mental flexibility. These impairments 
were not attributable to age, education or cerebrovascular risk factors. We found that 
early-onset bipolar patients are more likely to have a family history of psychiatric illness 
and have been treated with ECT more often, but they did not differ on other illness 
characteristics. The late-onset bipolar patients were more impaired than the early-onset 
bipolar patients in the performance of that involved the fronto-subcortical parts of the 
brain (speed and mental flexibility). This provides indirect evidence that late-onset bipolar 
patients may have greater frontostriatal dysfunction than early-onset patients, which 
could be due to a different neuropathology.
4.  How is cognitive functioning influenced by illness-related factors, medication and general 
health? (Question 4, Chapter 4)
The level of cognitive functioning in elderly bipolar patients varies greatly. While some 
patients may be more prone to long-term cognitive decline, others retain normal cognitive 
functioning. The etiology of cognitive functioning in bipolar disorder is not well known. 
Our study on risk factors in elderly patients (N=119) showed, as expected, that age is an 
important risk factor for developing cognitive impairment. With regard to the effect of 
premorbid IQ, patients with a higher premorbid IQ performed better on all measures. The 
main findings of this study show that increases in vascular risk factors and the number 
of hospital admissions are related to poorer outcomes for cognitive functioning. Patients 
who use lithium also have more impaired cognitive functioning, but this was explained by 
other risk factors and does not seem to be due to exposure to lithium itself. Other illness 
factors and alcohol consumption were not associated with cognitive functioning. These 
results have important implications for the treatment of elderly bipolar patients, such as 
the management of vascular risk factors, optimizing the pharmacological treatment of 
bipolar disorder and providing psychoeducation for patients and families.
5.  Do subjective cognitive complaints predict lower scores for cognitive tests? (Question 5 , 
Chapter 5)
Bipolar disorder is associated with cognitive impairment across a range of domains 
including executive function. As a consequence, bipolar patients might exhibit disturbed 
cognition in the awareness domain , such as awareness of cognitive functioning. In our 
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study elderly bipolar patients (N=101) had the same number of cognitive complaints 
compared with normal controls (N=74), but they showed worse cognitive deficits in several 
domains. Nearly 60% of elderly bipolar patients who were euthymic had considerable 
subjective cognitive complaints. Elderly bipolar patients with fewer subjective cognitive 
complaints had worse cognitive functioning. Furthermore, less awareness of cognitive 
deficits was especially associated with executive dysfunction. This suggests that poorer 
performance in measures that involve frontal lobes may be associated with the absence 
of insight into cognitive dysfunction and, most likely, with illness awareness. Age did not 
influence the subjective experience of cognitive dysfunction. This absence of subjective 
complaints in the presence of cognitive dysfunction may contribute to serious problems 
in everyday functioning and adherence to treatment regimens.
6. Is cognitive impairment progressive among older patients? (Question 6, Chapter 6)
Older individuals with bipolar disorder may exhibit greater cognitive decline over the 
years compared with elderly people who are mentally healthy, and they may be more 
at risk of developing dementia. We found that older adults with bipolar disorder exhibit 
worse cognitive dysfunction compared with healthy controls, but they showed no 
greater decline in cognition over a two-year period. Furthermore, no demographic or 
illness characteristics were associated with cognitive decline in attention, executive 
functioning and language functioning. Only the presence of manic symptoms predicted 
more cognitive decline in memory. The nature of this study meant that attrition might 
be a major problem. As a consequence, not all subjects completed follow-up. However, 
comparing the measurements at T2 and T1 the longitudinal sample performed better only 
on the learning condition of the 10 Word test and Occupation naming compared with the 
persons lost to follow up at T1, suggesting that the persons lost to follow up were slightly 
more cognitively impaired. Although cognitive impairment is a part of elderly bipolar 
disorder, it seems to remain stable over time.
Conceptual and methodological considerations
Neuropsychological functions in bipolar disorder
As stated in Chapter 1, it is important that a battery of tests for bipolar patients consist 
of the domains that have provided the most consistent evidence of impairment in these 
patients. Attention, verbal learning and memory, executive function, visuoconstruction 
and verbal fluency should therefore all be included in any such battery of tests. A 
neuropsychological test often taps different cognitive functions simultaneously. For 
instance, the Stroop test is associated with both selective attention and executive 
functioning (Bush et al., 2000).
Another example is the overlap between executive functioning and verbal functioning 
in the verbal fluency test. In this test a subject has to generate as many words as he can 
according to category or initial consonant. This requires subjects to develop strategies 
in their search for words. Reduced verbal fluency may be associated with the impaired 
functioning of different brain regions, not only those that mediate language but also 
those that mediate executive functions. The cognitive domains examined in this study 
seem to be part of the same neural network circuit of the brain that appears to be 
impaired in patients with a bipolar disorder (see 1.3). However, it is impossible to indicate 
the exact node in the network that is dysregulated on the basis of a patient’s performance 
of a neuropsychological test.
Mental effort
Some researchers relate cognitive impairment in different domains in psychiatric patients 
to one explanatory underlying mechanism. For instance, Olley et al. (2005) have suggested 
that reduced cognitive effort may explain reduced memory functioning in bipolar disorder. 
We found that mental effort was reduced in bipolar patients. However, the effect size of 
mental effort tests was smaller than the effect size of other tests and the correlation 
of mental effort with other cognitive variables was not strong. A finding by Ojeda et 
al. (2010) in schizophrenic patients is intriguing. They found that tests were related to 
different cognitive domains in patients compared with healthy controls. Working memory 
predicts the performance of fluency tasks in patients with schizophrenia, whereas the 
best predictor in the healthy controls (and also the patients with a better performance 
on fluency) was processing speed. The association of verbal fluency performance with 
working memory could mean that the fluency task demanded a higher level of cognitive 
functioning for the schizophrenic patient. Patients with other psychiatric illnesses besides 
schizophrenia, such as bipolar disorder, may also reflect in their cognitive performance 
different underlying mechanisms that are different from normal subjects. To summarize, 
tests may demand more mental effort of psychiatric patients than of normal controls, 
and this may result in cognitive impairment in several domains.
Integrative model of cognitive decline and bipolar disorder
Many possible mechanisms seem to underlie cognitive deficits in older adult patients 
with bipolar disorder. They may include genetic abnormalities that present early during 
the illness and cause cognitive deficits, as can also be seen in the study of first-grade 
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family members (Bora et al., 2009). Cognitive deficits can also present later in life when 
they are combined with the effects of the illness, such as frequent mood episodes, 
medical comorbidity, substance use, (pharmaco)therapy, and the effects or aging. Our 
study suggest that age at onset, vascular diseases and the number of hospitalizations 
are especially important risk factors. This complex relationship between risk factors and 
cognitive deficits is illustrated in the cascade model in Figure 1. Cognitive impairment can 
originate at any stage during bipolar disorder but according to our findings, the commonest 
cause seems to be a lifetime accumulation of toxic processes and cerebrovascular brain 
changes.
The brains of bipolar patients may be more vulnerable to toxic effects throughout 
their lives. This explanation is supported by neuroimaging studies indicating that older 
patients with a bipolar disorder show increased signs of atrophy and cerebral vascular 
lesions compared with normal aged-matched controls (Beyer et al., 2009). Postmortem 
studies show glia cell reductions throughout the brain tissues of patients with bipolar 
disorder (Brauch et al., 2006). Although the causal mechanism of the cell reduction is 
not known, this might put patients with bipolar disorder at a greater risk of developing 
cognitive deterioration.
Statistical issues
Sampling
The inclusion and exclusion criteria meant that there was a selection bias with respect 
to the group of bipolar patients. The patients had to be euthymic, without a history of 
alcohol dependency. As a result, the sample consisted mostly of outpatients rather than 
patients who were hospitalized and acutely ill. In addition, patients from all over the 
Netherlands were included, also patients who were not in psychiatric care at the time of 
testing. This means a very broad sample of relatively well-functioning bipolar patients 
was obtained.
In general, the problem of attrition (drop-out) in a follow-up study is obvious and difficult 
to overcome. In our study thirty-two subjects (12 patients and 20 controls) could not 
be tested at follow-up due to budget limitations. Comparing the measurements of the 
persons lost to follow up at baseline and the longitudinal sample at follow-up, we found 
small differences in cognition, suggesting that the persons lost to follow up were slightly 
more cognitively impaired. Ten patients were excluded from the follow-up because they 
were not euthymic, which suggests that a subgroup might be more cognitively impaired 
after two years. However, this did not influence the results of our follow-up study, in which 
older adults with bipolar disorder who were euthymic after two years showed worse 
cognitive function compared with healthy controls, but no greater decline in cognition 
over those two years.
Measurement of independent variables
Whenever possible, neuropsychological instruments were used that were validated for the 
elderly population, as is also the case for measurements of mood symptoms (CES-D and 
YMRS). Throughout the study self-reported measures were used. In the first assessment 
individuals already had memory and cognitive problems that may have caused recall bias. 
This concerned the recollection of their illness history, medical history and subjective 
cognitive complaints. This could mean that subjects underreported aspects of their illness, 
which may have weakened the possible associations between risk factors and cognitive 
functioning. In the future, longitudinal studies need to follow patients for longer periods 
in order to overcome the information bias arising from recall bias.
Statistical power, effect sizes and validity
Given that the results of cognitive assessments in the psychiatric population are less 
definite than in neurological populations, no great differences were expected between 
bipolar patients and controls. Therefore, studies on cognition in the psychiatric population 
need a relatively large sample size to have satisfactory statistical power. 
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Figure 1. Cascade model of cognitive decline in elderly bipolar patients
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about cognitive impairment and specific psychoeducational rehabilitation programmes 
may be necessary. There is a distinction between substantial global cognitive impairment 
due to dementia and the cognitive impairment that we found in elderly bipolar patients. 
Patients may therefore benefit from cognitive remediation therapies. These therapies 
usually target the improvement of one primary neuropsychological domain, such as 
memory or speed of processing, using compensatory and restorative approaches. 
Combined with lifestyle changes, such as improved physical fitness and stress reduction, 
the results may translate into everyday functioning. Studies to date show no agreement 
on which cognitive functions are associated with impaired daily functioning: executive 
functions (Gildengers et al., 2007), memory (Martinez-Aran et al., 2007), language 
functioning (Jaeger et al., 2007), to mention only a few. Remediation should therefore 
focus on an individual patient’s specific impairment. Neuropsychological assessment can 
detect the specific domains requiring treatment.
As is shown in Chapter 3, it is important to be aware of and to manage vascular risk factors 
and their associated complications in order to protect bipolar patients from cognitive 
dysfunction. It is also important to reduce the negative impact of bipolar disorder on 
patients’ cognitive functioning. This suggests that more aggressive treatment could 
help prevent cognitive impairment. Relapse should be prevented by optimizing the 
pharmacological treatment and providing patients and their families with adequate 
psychoeducation, which should also include aspects of cognitive functioning (Goldberg 
and Burdick, 2008).
The lack of correspondence between self-reported cognitive functioning and cognitive 
test performance is a complex issue in neuropsychology. In this study, patients with fewer 
subjective cognitive complaints showed poorer attentional and executive functioning 
than patients with many cognitive complaints. It is therefore recommended that bipolar 
patients, especially elderly patients, regardless of whether they have complaints, be 
objectively evaluated during at least a brief neuropsychological assessment because it is 
probable that a number of the patients who do not complain will show some kind of real 
cognitive impairment. The cognitive status of bipolar patients should be an important 
issue in their treatment, regardless of subjective complaints. 
Neuropsychological assessments may also provide a useful baseline in order to compare 
future changes. The cognitive impairment that is presented by at least a subgroup 
of elderly bipolar patients shows a profile that is typical of mild cognitive impairment 
(MCI). MCI patients generally are more impaired in episodic memory than bipolar disorder 
patients (Silva et al., 2009). It could be that a subgroup of bipolar patients suffers from 
The sample sizes of our study (119 bipolar patients and 78 controls) and of our follow-
up study (65 patients and 42 controls) were large compared to other neuropsychological 
studies of bipolar patients to date. The effect sizes of the cognitive measures indicated 
moderate to large effects, so that it was possible to detect clinically relevant differences. A 
general definition of a neuropsychological deficit is a score below two standard deviations 
of the mean test score. According to this definition, the patients with an impairment for 
a test in this study ranged from 5% to 39%, which means that more than a third of the 
patients showed memory impairment. 
The degree to which test performance corresponds to “real world” performance (the 
“ecological validity” of neuropsychological tests) is receiving increasing attention. A 
review demonstrated that there was only a moderate degree of correspondence between 
neuropsychological evaluations and measures of ”real world” cognitive skills, and many 
individual tests were not, or only weakly, related to outcome measures (Chaytor et al., 
2003). The neuropsychological examination itself could predict 30% of “real world 
functioning”, and the ability of neuropsychologists to predict “real world functioning” 
increased when additional information (such as observations of participants performing 
the test, mood and neuropsychiatric symptoms) was taken into account. Although 
only limited additional information was used in our study, our results provide several 
indications that the differences between groups in our study are more than statistically 
significant. Indications for clinical relevance are, besides the moderate to large effect sizes, 
the consistency of our findings with earlier studies and the consistency of the cognitive 
domains that are affected.
Clinical relevance
This study suggests an important clinical implication of cognitive impairment in elderly 
bipolar patients, namely, that cognitive deficits may severely impact on these patients’ 
social and occupational functioning and their quality of life. A recent review showed that 
enduring aspects of cognitive impairment even in euthymic bipolar patients are associated 
with inferior psychosocial functioning after adjusting for relevant demographic and 
clinical variables (Wingo et al., 2009). A patient might be doing well in terms of mood 
symptoms but treatment might fail if cognitive functioning is not taken into account.
Compliance with treatment regimens can be severely compromised by cognitive deficits, 
sometimes making it necessary to adapt treatment strategies. Information for patients 
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MCI, since MCI is very prevalent in the elderly (16.6 % of people over the age of 60 years 
(Artero et al., 2006)). Since MCI patients are more likely to develop Alzheimer’s disease, 
it is important to follow up subgroups of bipolar patients and determine if the cognitive 
deficits for a subgroup of patients would aggravate and evolve in a dementing disorder. 
Future research
As outlined earlier, this study sheds light on several aspects of the nature and etiology of 
cognitive impairment in bipolar disorder that may have important clinical implications. 
For example, further studies need to examine whether graduate bipolar patients do 
indeed experience problems in everyday life and whether neuropsychological and 
psychoeducational rehabilitation can help improve functioning. There is also a need for 
prospective studies that follow bipolar samples within the broad range of the spectrum, 
using detailed descriptions of pharmacotherapy and clinical features. An important issue 
to be addressed is whether cognitive impairment in bipolar disorder might be associated 
with relapse and poor clinical outcomes. 
Because there is a delay of at least four years in the diagnosis of bipolar disorder in a group 
of patients, especially in elderly patients, (Stang et al., 2006) long-term follow-up studies 
are needed in order to establish the effect of faster and adequate treatment on cognition.
The correlation with new, more detailed and functional neuroimaging data could 
contribute to our understanding of how neuronal circuits work together. At last, studies 
on emotional processing and social cognition (Theory of mind) seem very promising 
(Yatham et al., 2010). Euthymic bipolar patients’ ability to affectively process might be 
limited because emotional information interferes with cognitive processing. In this way 
imaging studies might detect different neural mechanisms even if patients and controls 
perform similarly on test scores.
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Summary
This thesis focuses on cognitive function in elderly patients with bipolar disorder. Chapter 
1 provides background information on the topic, first an introduction to the relevance of 
bipolar order in late life followed by a brief history on the field of bipolar disorder and 
cognition. Nowadays, a growing number of patients with a bipolar disorder reach an older 
age. This has important implications for the delivery of health service to this group. The 
last ten years many studies have demonstrated that patients with bipolar disorder have 
impaired functioning across a range of cognitive domains, even when they are stable. 
Imaging studies have shown that the anterior limbic network seems to be involved that 
may be responsible for the core mood symptoms but also for cognitive functioning in 
bipolar disorder. Still little information is available on bipolar disorder in later life. Many 
factors may contribute to cognitive impairment in elderly patients: illness characteristics 
such as age at onset and repeated mood episodes, medical comorbidity, substance use, 
or iatrogenic effects of medication. A neuropsychologist is confronted with a kind of 
jigsaw puzzle and it is often difficult to discriminate between the contribution of these 
different factors. In a short overview on measurement of cognitive function tests the 
cognitive domains are summarized that should be included in a research battery for 
bipolar patients; attention, verbal learning and memory and executive function, visuo-
construction and verbal fluency. The research questions of this study are the following:
-  Do older patients with an early onset Bipolar-I disorder in a euthymic state exhibit 
cognitive deficits compared with normal elderly people?
-  Do older patients with bipolar disorder who are in a eythymic state exhibit cognitive 
deficits compared with normal elderly people?
-  Do late-onset bipolar patients show more cognitive decline than early onset bipolar 
patients?
-  How is cognitive functioning influenced by illness-related factors, medication and 
general health?
- Do subjective cognitive complaints predict lower scores for cognitive tests?
- Is cognitive impairment progressive among older patients?
To answer the above-mentioned questions a study was instigated in which 119 patients 
were recruited from outpatient clinics in four regions of the Netherlands and with 
help from the Dutch bipolar patients association (VMDB). Subjects were reported to be 
euthymic for at least three weeks by their psychiatrist, and none of the patients had a 
primary diagnosis of alcohol dependence or substance abuse or a clinical diagnosis of 
dementia. A comparison group consisted of 78 healthy persons. 
In chapter 2 the results of our pilot study is presented. Fifteen older early onset bipolar-I 
patients had poorer cognitive functioning across a range of cognitive functions, including 
selective attention and verbal fluency (both aspects of executive functioning), verbal 
memory and mental effort compared to 15 matched comparison subjects without mood 
disorder or memory complaints. Patients were also slower than controls but although 
effect sizes were large, these measures did not reach level of significance. The differences 
between patients and controls were not attributable to symptoms of depression, 
severity of illness (as measured by the number of admissions in psychiatric hospitals), the 
occurrence of a psychotic episode in the past, or the current level of mania symptoms 
was not significantly correlated with cognitive performance. Although the sample size 
was modest, the differences between bipolar patients and comparison subjects were 
large enough to be statistically significant. This supports the notion that the differences 
between patients and comparison subjects are not only statistically significant, but 
also clinically relevant. A limitation of the study is that the effect of medication on test 
performance may have biased the interpretation of neuropsychological tests. Our findings 
are consistent with a growing body of evidence that bipolar patients experience cognitive 
deficits during mood stable episodes too and across a range of cognitive domains, 
including attention, executive functioning, verbal declarative memory and psychomotor 
speed. This may suggest a trait-related dysregulation, causing bipolar patients to have 
cognitive deficits, even when euthymic and regardless of their age.
In Chapter 3 cognition and clinical characteristics of early and late onset bipolar patients 
were compared. We studied early (<40 years) onset bipolar patients (N=59) and late 
onset bipolar patients (N=60). Both bipolar groups demonstrated substantial poorer 
neuropsychological functioning when compared with the comparison group (N=78). 
Late onset bipolar patients showed poorer performances with regard to psychomotor 
performance, word fluency and mental flexibility. These poorer performances were not 
attributable to age, education or cerebrovascular risk factors. We found that early onset 
bipolar patients are more likely to have a family history of psychiatric illness and have 
more often been treated with ECT but they did not differ on other illness characteristics. 
The late onset bipolar patients performed less than the early onset bipolar patients of 
tests that suggest involvement of fronto-subcortical parts of the brain (speed and 
mental flexibility). This provides indirect evidence that late onset bipolar patients may 
have greater frontostriatal dysfunction than early onset patients, which could be due to 
a different neuropathology. A limitation in the study was the difficulty of ascertaining 
the exact age at onset and comparing our findings with those of studies with different 
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criteria for age of onset. Recent studies applied mostly the age at which the first mood 
episode that met full diagnostic criteria was reported, and this also applies to our study. 
Chapter 4 contains the study on risk factors on cognitive functioning in elderly patients 
with bipolar disorder. The main findings of this study show that more vascular risk factors 
and a greater number of hospital admissions are related to poorer outcome of cognitive 
functioning. Patients who are using lithium also have poorer cognitive functioning, but 
this can be explained by other risk factors and does not seem due to the exposure to 
lithium itself. Other illness factors and use of alcohol were not associated with cognitive 
functioning. We have used a cross-sectional design that required patients, some of whom 
had cognitive problems, to retrospectively recall a good deal of information. This may have 
biased our results. Nevertheless, the results have important implications for the treatment 
of elderly bipolar patients. Awareness and management of vascular risk factors and its 
complications are important to protect bipolar patients against cognitive dysfunction. 
Furthermore, relapse should be prevented by optimizing the pharmacological treatment 
and providing adequate psycho-education for patients and families
In chapter 5 we examined whether subjective cognitive complaints were associated 
with objective neuropsychological performance and to consider the role of frontal lobe 
dysfunction in the awareness of cognitive impairment. Bipolar elderly patients (N=101) 
had the same number of cognitive complaints compared to comparison subjects (N=74), 
but they showed worse cognitive functioning in several domains. Nearly 60% of elderly 
bipolar patients who were euthymic had considerable subjective cognitive complaints. 
Bipolar elderly patients with less subjective cognitive complaints had worse cognitive 
functioning. Furthermore, a lesser awareness of cognitive deficits was associated with 
especially poorer performances on attention and executive tests. Impaired awareness of 
cognition might be a reflection of cognitive detoriation and could influence treatment. 
Age did not have influence on the subjective experience of cognitive dysfunction. 
The present study required individuals, some of which having memory problems, to 
retrospectively recall a good deal of information. Direct assessment of everyday functions 
and diary methods may be more powerful instruments to identify cognitive problems and 
how frequent they occur.
In the follow up part of the study (Chapter 6) older adults with bipolar disorder (N=65) 
exhibit worse cognitive dysfunction compared to healthy controls (N=42), but no greater 
decline in cognition over two years. Furthermore, no demographic or illness characteristics 
were associated with cognitive decline in attention, executive and language function. 
Only manic symptoms predicted cognitive decline in memory. Unfortunately, we had not 
from all subjects follow up assessments. However, comparison of the baseline data of 
persons lost to follow up with the longitudinal sample showed only differences in the 
learning condition of the memory test and in one of the verbal fluency tests. This suggests 
that cognitive functioning in both groups were comparable. We concluded that although 
poorer cognitive functioning is a part of elderly bipolar disorder is seems to be rather 
consistent in time.
In chapter 7 the general discussion and the principal findings of the study are summarized. 
Methodological issues and conceptual considerations are discussed and, finally, the clinical 
relevance of the findings is discussed and suggestions are made for further research. This 
study confirmed the importance of being aware of poor cognitive functioning in elderly 
bipolar patients and of the risk factors that seem to contribute to this poor functioning. 
Poor cognitive functioning may have a negative impact on social and occupational 
functioning and on the quality of life of patients. Compliance to treatment regimens 
could be severely compromised by poorer cognitive functioning. Because of the lack of 
associations between self-reported cognitive functioning and cognitive test performance 
it is recommended that all older bipolar patients irrespective of cognitive complaints 
should be objectively evaluated at least by a brief neuropsychological assessment. 
Future research should focus on problems that patients experience in everyday life 
and if neuropsychological and psychoeducational rehabilitation can help to improve 
functioning.
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de patienten mocht een diagnose van alcoholafhankelijkheid, middelenmisbruik of een 
klinische diagnose dementie hebben. De controlegroep bestond uit 78 gezonde ouderen.
In hoofdstuk 2 wordt de pilotstudie beschreven. Vijftien oudere patiënten met een 
bipolaire I stoornis presteerden vergeleken met vijftien gematchte controle personen 
zwakker wat betreft verschillende cognitieve functies, waaronder selectieve aandacht en 
verbale fluency (beide aspecten van executief functioneren), verbaal geheugen en mentale 
inspanning. Patiënten met een bipolaire I stoornis waren ook trager maar de verschillen 
waren niet significant - hoewel de effectgrootte groot was. De verschillen tussen patiënten 
en controle personen konden niet worden toegeschreven aan stemmingssymptomen, 
ernst van de ziekte (zoals gemeten middels het aantal keer dat iemand opgenomen is 
geweest in een psychiatrisch ziekenhuis), het doormaken van een psychose in het verleden 
of de huidige manische symptomen. 
Hoewel het aantal patienten bescheiden is, zijn de verschillen tussen patiënten en 
controle personen groot genoeg om statistisch significant te zijn. Dit gegeven ondersteunt 
de gedachte dat de gevonden verschillen ook klinisch relevant zijn. Een beperking van 
de studie is dat de interpretatie van de neuropsychologische tests misschien vertekend 
wordt door de effecten van medicatie. Onze bevindingen zijn in overeenstemming met 
het toenemend bewijs dat bipolaire patienten cognitieve problemen ervaren gedurende 
stabiele stemmingsepisodes van de ziekte en met betrekking tot verschillende cognitieve 
domeinen zoals aandacht , executief functieneren, verbaal geheugen en psychomotorisch 
tempo. Dit kan wijzen op een trait gerelateerde dysregulatie die er voor zorgt dat bipolaire 
patienten cognitieve problemen hebben, ongeacht of ze euthym zijn of dat ze jong of oud 
zijn.
In hoofdstuk 3 worden het cognitief functioneren en de klinische kenmerken vergeleken 
tussen bipolaire patiënten met een vroeg begin en met een laat begin van de stoornis. 
Hiervoor bestudeerden wij 59 patiënten met een vroeg begin (voor het 40e jaar) en 60 
patiënten met een laat begin (vanaf het 40e jaar). Beide groepen bipolaire patiënten 
vertoonden duidelijke neuropsychologische afwijkingen ten opzichte van een groep controle 
personen (N=78). Patiënten met een laat begin presteerden zwakker met betrekking tot 
psychomotorisch tempo, verbale fluency en mentale flexibiliteit dan patiënten met een 
vroeg begin. Deze zwakkere prestaties werden niet veroorzaakt door leeftijd, opleiding 
of vasculaire risicofactoren. Wij vonden dat patiënten met een bipolaire stoornis met een 
vroeg begin meer kans hadden dat iemand in de familie ook een psychiatrische ziekte 
heeft en dat ze vaker behandeld waren met ECT, maar ze verschilden niet met betrekking 
tot overige ziektefactoren. De patiënten met een laat begin presteerden zwakker dan de 
patiënten met een vroeg begin op tests die betrokkenheid veronderstellen van fronto-
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Dit proefschrift gaat over op het cognitief functioneren van oudere patiënten met een 
bipolaire stoornis. In hoofdstuk 1 worden de achtergronden van het onderzoek toegelicht. 
Vandaag de dag bereiken steeds meer patiënten met een bipolaire stoornis een hoge 
leeftijd. Dit heeft belangrijke consequenties voor de zorg die aan deze groep wordt 
geboden. De afgelopen tien jaar hebben diverse onderzoeken aangetoond dat patiënten 
met een bipolaire stoornis cognitieve problemen in verschillende domeinen hebben, 
ook al zijn zij stabiel (euthym). Beeldvormend onderzoek heeft aangetoond dat het 
anterieure limbische netwerk bij deze cognitieve problemen betrokken is. Zij is mogelijk 
verantwoordelijk voor zowel de kernsymptomen van de stemming, als voor het cognitief 
functioneren van bipolaire patiënten. Over de bipolaire stoornis op latere leeftijd is 
echter nog weinig bekend. Er kunnen veel verschillende factoren bijdragen aan cognitieve 
problemen bij oudere patiënten: ziektekenmerken zoals leeftijd waarop de ziekte is 
ontstaan (age at onset), stemmingsepisodes, medische comorbiditeit, middelenmisbruik 
en iatrogene effecten van medicatie. Een neuropsycholoog wordt geconfronteerd met een 
ingewikkelde puzzel en het is vaak lastig om te onderscheiden wat de bijdrage is van deze 
verschillende factoren. 
In een kort overzicht van het meten van cognitieve functies worden de cognitieve domeinen 
opgesomd die onderdeel zouden moeten vormen van een testbatterij in het onderzoek bij 
bipolaire patiënten: aandacht, verbaal geheugen, executieve functies, visuo-constructie en 
woordvlotheid (verbale fluency). De onderzoeksvragen van deze studie zijn als volgt:
-	Vertonen patiënten met een vroeg ontstane bipolaire I stoornis die euthym zijn 
cognitieve stoornissen vergeleken met een groep gezonde ouderen?
-	Vertonen patiënten met een bipolaire stoornis die euthym zijn cognitieve stoornissen 
vergeleken met een groep gezonde ouderen?
-	Vertonen patiënten met een laat ontstane bipolaire stoornis meer cognitieve 
achteruitgang dan patiënten met een vroeg ontstane bipolaire stoornis?
-	Wat is de invloed van ziektekenmerken maar ook medicatie en meer algemene 
gezondheidsfactoren op het cognitief functioneren?
-	Voorspellen subjectieve klachten zwakkere prestaties op tests die de cognitie meten?
-	Is de cognitieve achteruitgang van bipolaire patiënten progressief?
Om de bovenstaande vragen te kunnen beantwoorden is een studie opgezet waarbij 119 
patiënten zijn geworven bij psychiatrische poliklinieken in vier verschillende regio’s van het 
land en met hulp van de Vereniging van Manisch Depressieven en Betrokkenen (VMDB). 
Patienten moesten tenminste drie weken euthym zijn volgens de psychiater, en geen van 
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subcorticale hersengebieden (snelheid en mentale flexibiliteit). Dit verschaft indirect 
bewijs dat patiënten met een laat begin ernstigere frontostriatale dysfunctie vertonen 
dan patiënten met een vroeg begin. Dit verschil kan te wijten zijn aan verschillende 
neuropathologische processen.
Een beperking van dit onderzoek is de moeilijkheid om de exacte leeftijd van de patient 
te bepalen waarop de ziekte is begonnen. Ook moeten wij onze resultaten vergelijken 
met studies die van andere criteria zijn uitgegaan om age at onset te bepalen. De meeste 
recente studies zijn uitgegaan van de leeftijd waarop de eerste stemmingsepisode die aan 
de volledige diagnostische criteria voldoet werd gerapporteerd. Dit geldt ook voor onze 
studie.
Hoofdstuk 4 beschrijft de studie naar de risicofactoren die het cognitief functioneren bij 
oudere patienten met een bipolaire stoornis beïnvloeden. De belangrijkste bevindingen zijn 
dat meer cardiovasculaire risicofactoren en een groter aantal opnames in een psychiatrisch 
ziekenhuis een negatieve invloed hebben op het cognitief functioneren. Patiënten die 
lithium gebruiken zijn ook ernstiger cognitief gestoord, maar dit kan worden verklaard 
door de combinatie met andere risicofactoren en is niet te wijten aan blootstelling aan de 
lithium op zich. Andere ziektefactoren en het gebruik van alcohol waren niet van invloed 
op cognitief functioneren. We zijn uitgegaan van een cross-sectioneel design waardoor 
patiënten die soms cognitieve stoornissen vertoonden, retrospectief een behoorlijke 
hoeveelheid informatie moesten rapporteren. Dit heeft onze resultaten mogelijk 
vertekend. De resultaten hebben belangrijke consequenties voor de behandeling van 
oudere bipolaire patiënten. Bewustzijn en behandeling van cardiovasculaire risicofactoren 
en de complicaties die hierdoor optreden zijn belangrijk om patiënten met een bipolaire 
stoornis te beschermen tegen cognitieve achteruitgang. Bovendien moet een terugval zo 
veel mogelijk worden voorkomen door de farmacologische behandeling te optimaliseren 
en door adequate psycho-educatie aan de patiënt een zijn omgeving te bieden.
In hoofdstuk 5 is onderzocht of subjectieve cognitieve klachten ook een verband houden 
met de objectieve neuropsychologische testprestaties. Ook hebben wij gekeken naar de 
rol die het frontaal dysfunctioneren speelt in het bewustzijn van cognitieve problemen. 
Oudere bipolaire patiënten (N=101) hadden veel cognitieve klachten vergeleken met een 
groep normalen (N=74), maar ze vertoonden zwakkere prestaties in verschillende cognitieve 
domeinen. Bijna 60% van de oudere bipolaire patiënten die euthym waren hadden 
aanzienlijke subjectieve klachten. Bipolaire patiënten die minder subjectieve klachten 
hadden functioneerden cognitief slechter. Verder werd een verminderd bewustzijn van 
cognitieve problemen vooral in verband gebracht met zwakkere prestaties op met name 
aandacht en executieve tests. Een verminderd bewustzijn van cognitieve problemen 
kan het gevolg zijn van verminderd cognitief functioneren en kan de behandeling 
negatief beïnvloeden. Leeftijd hing niet samen met het subjectief ervaren van cognitieve 
problemen. De huidige studie vroeg aan onderzoekspersonen (waarvan sommigen met 
geheugenproblemen of andere cognitieve problemen) om veel informatie te herinneren. 
Het direct meten van het alledaags functioneren en het bijhouden van dagboeken om 
klachten bij te houden zijn wellicht geschikte instrumenten om cognitieve problemen vast 
te stellen en om de frequentie waarmee ze optreden te meten.
In het follow-up gedeelte van de studie (hoofdstuk 6) vertoonden oudere patiënten met 
een bipolaire stoornis (N=65) zwakkere prestaties op cognitieve tests in vergelijking met 
een groep gezonde controles (N=42), maar niet een sterkere achteruitgang na twee jaar. 
Demografische kenmerken en ziektekenmerken houden geen verband met het cognitief 
functioneren voor wat betreft van aandacht, executieve- en taalfuncties. Alleen manische 
symptomen voorspelden een achteruitgang in het geheugen.
Helaas konden niet alle patiënten meedoen aan de follow-up meting. Maar wanneer 
de prestaties op de eerste meting van de personen die zijn uitgevallen bij de follow-up 
werden vergeleken met de longitudinale groep, werden alleen verschillen gevonden op de 
leerconditie van de geheugentest en op een verbale fluency test. Dit lijkt erop te wijzen 
dat beide groepen redelijk vergelijkbaar zijn. Wij concludeerden dat hoewel cognitieve 
problemen horen bij oudere patiënten met een bipolaire stoornis, deze problemen wel 
constant in de tijd lijken te zijn.
In hoofdstuk 7, de algemene discussie, worden de belangrijkste bevindingen van deze 
studie samengevat. Methodologische vraagstukken en conceptuele veronderstellingen 
komen aan bod en uiteindelijk wordt de klinische relevantie van de studie besproken en 
worden er suggesties gegeven voor verder onderzoek.
Deze studie bevestigt het belang van het zwakke cognitief functioneren bij oudere 
bipolaire patiënten en de verschillende risicofactoren die deze zwakke cognitieve prestaties 
veroorzaken. Een verminderd cognitief functioneren kan een grote invloed hebben op 
het sociaal en beroepsmatig functioneren en de kwaliteit van leven van patiënten. De 
therapietrouw kan in gevaar komen als gevolg van cognitieve problemen. Omdat er 
geen verband was tussen cognitieve klachten die door de patiënt werden aangeven en 
de objectieve testprestaties, wordt aanbevolen om bipolaire patiënten, in het bijzonder 
ouderen met of zonder subjectieve klachten, objectief te onderzoeken door middel van 
een kort neuropsychologisch onderzoek. Toekomstig onderzoek moet zich richten op de 
problemen die patiënten ervaren in het dagelijks leven. Ook dient onderzocht te worden 
of een neuropsychologische behandeling en psycho-educatie kunnen helpen om het 
algemeen functioneren te verbeteren. 
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Gezondheid werd het mogelijk voor mij om één dag in de week aan onderzoek te besteden, 
een dag die ik nog steeds koester. In de eerste plaats dank ik natuurlijk Hannie Comijs, wier 
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Van mijn huidige collega’s op de afdeling wil ik een aantal speciaal noemen. Paul David 
Meesters: op verschillende momenten hebben onze wegen elkaar gekruist en daar ben ik 
erg dankbaar voor. Nu zijn wij als een soort ‘onderzoekstandem’ bezig, ik met de bipolaire 
ouderen en jij met de late onset schizofrenie patiënten. In het tempo waarin jij bezig bent 
zul jij ook snel de eindstreep in zicht krijgen. Annemieke Dols: bezig onderzoek op te zetten 
bij oudere bipolaire patiënten en op haar eigen open manier daarbij mensen betrekkend. 
Caroline Sonnenberg: inhoudelijk manager, als geen ander betrokken bij de afdeling en de 
mensen die daar werken. Jeroen de Jong, zonder jou was de omslag er nooit in deze vorm 
gekomen. Piet Eikelenboom, altijd meedenkend en bezig het algemene met het specifieke 
te verbinden. Caroline Tielkes, thans werkzaam in Hilversum, maar wij hebben toch acht 
en een half jaar de kamer gedeeld en ik denk daar nog steeds met veel plezier aan terug. 
En verder in willekeurige volgorde: Margriet Wegloop-de Maat, Audrey van Schaik, Yolande 
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In de eerste plaats wil ik alle zestig plussers, met of zonder bipolaire stoornis, bedanken die 
zich belangeloos voor dit onderzoek hebben ingezet. Ik heb het persoonlijke contact met 
hen altijd erg plezierig gevonden en ik heb ook veel van hen geleerd. Hopelijk komt door 
middel van dit proefschrift iets van die kennis bij een grotere groep mensen terecht. Verder 
wil ik nu kort de weg beschrijven die tot dit proefschrift heeft geleid en de mensen noemen 
die ik op die weg ben tegengekomen en aan wie ik dank verschuldigd ben.
Nadat ik als puber De psychologische ontwikkeling van het kind uit mijn vaders boekenkast 
had gepakt was niet alleen mijn toekomstige studiekeuze bepaald maar werd tevens 
mijn belangstelling gewekt voor de experimenten en het onderzoek die daarin werden 
beschreven. Eenmaal halverwege de studie werd mij door een hoogleraar in alle ernst 
medegedeeld dat waar het eigenlijk om gaat in de wetenschap is dat je naam boven 
een artikel wordt gelezen door die mensen die zich over de gehele wereld met hetzelfde 
onderwerp bezig houden. Omdat mij dat een weinig aantrekkelijk vooruitzicht leek, hield ik 
vanaf dat moment nadrukkelijk de optie open om ook praktisch met mensen bezig te zijn, 
in de vorm van diagnostiek en behandelen.
Na de studie heb ik eigenlijk altijd een combinatie gezocht van enerzijds het betrokken 
en vaak boeiende contact met patiënten en anderzijds de afstand en verdieping van het 
onderzoek. Een van de eerste collega’s die daarbij als voorbeeld voor mij diende was Jos 
de Jonghe toen ik op de afdeling Duinoord van het toenmalige Vogelenzang werkte. Zijn 
laagdrempelige instelling en inzet voor de professionalisering van het vak maakte op mij 
een diepe indruk. Hier werd ook mijn belangstelling voor de doelgroep ouderen in een 
psychiatrische setting gewekt. Toen ik later bij het Psychiatrisch Ziekenhuis Amsterdam 
(thans Mentrum/Arkin) ging werken was de afdeling Onderzoek en Onderwijs en 
Ontwikkeling een motiverende omgeving, met Jack Dekker en Joseph Iping aan het hoofd. 
Jack was ook heel behulpzaam bij het tot stand komen van mijn eerste publicaties.
Toen ik mijn eigen onderzoek wilde gaan opzetten, werd de kiem daarvoor gelegd door de 
patiënten die ik zag op de opname afdeling voor ouderen (GAPZ). De gesprekken hierover 
met psychiater Paul Naarding maakten de onderzoeksplannen veel concreter. Later op zijn 
huidige werkplek heeft Paul mij nog erg geholpen met het aanboren van patiëntenstromen. 
Nadat ik een onderzoeksvoorstel had geschreven en het was goedgekeurd door de 
Medisch Ethische Commissie, heeft Jeroen Zoeteman als aankomend psychiater met 
zijn onverschrokken instelling en enthousiasme een belangrijk aandeel gehad in de 
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Pijnenburg, Niels Prins, Karin Vermond, Agnes Heus, Rikie Kleverwal, Moniek van Dijk, Gerard 
Vromans, Joanneke Sikkema, Eric Stolp, Gerdine van Tol, Jacqueline Onrust, Bernadette van 
Es, Marije van der Hulst, Gert Jan Kesseler, Jan Willem Pijpers, Mourien Roest, Hannie Spel, 
Pia Verheul, Annemieke Westenberg, Marzenka Matthée, Natasha Girwar, Debbie van der 
Velden, Kitty Baars, Ineke van Keeken, Jopi van der Spek, Marijke van der Toolen en Iet van 
de Velden in Haarlem. Als co-auteur dank ik Cees Jonker, Cora Kerssens en Helmy Pennarts. 
Alle SPV-ers, behandelaren, stagiaires en andere opleidelingen binnen GGZ inGeest en 
erbuiten die behulpzaam zijn geweest bij het onderzoek bedank ik eveneens.
Praktisch alle patiënten heb ik de eerste keer zelf gesproken en getest, en ook een aanzienlijk 
deel van de controles en hermetingen, maar ik ben bij de dataverzameling en de invoer ook 
geholpen door Trudy Bruins en Christel Burger, die er een scriptie over schreven. Arnoud 
Kas en Lisa van Mierloo hebben ook belangeloos meegewerkt aan de dataverzameling. 
Anna Pauw en Jasper Nieuwesteeg waren onmisbaar bij de datainvoer en (ook weer) 
uitvoer. Een heel belangrijke rol heeft Johan Schokker gehad, niet alleen vanwege zijn 
deskundigheid bij de data-analyse maar bovenal als vriend. Vrienden en familie bedank ik 
die me hebben gesteund de afgelopen jaren. En tot slot Elsbeth Greven, voor haar kennis 
van de neuropsychologie en psychiatrie en nog veel meer. Zoals bij zoveel dingen ben je 
me voor, maar daar kan ik dan weer van profiteren. Je liefde en steun hebben mij in staat 
gesteld om dit project tot een goed einde te brengen.
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Uitgeest en het Murmellius Gymnasium in Alkmaar te hebben gevolgd studeerde 
hij van 1983 tot 1989 ontwikkelingspsychologie aan de Universiteit van Amsterdam. 
Van 1989 tot 1992 werkte hij als onderzoeker bij een studie naar het herstel van afasie 
aan het Max-Planck-Institut für Psycholinguistik. Hij behaalde in 1993 het aanvullend 
examen neuropsychologie aan de Vrije Universiteit en maakte aansluitend kennis met de 
ouderenpsychiatrie op de afdeling Duinoord van Psychiatrisch Ziekenhuis Vogelenzang. 
Vanaf 1994 tot 1996 werkte hij als neuropsycholoog bij de afdeling neurologie van het 
Sint Lucas Ziekenhuis te Amsterdam. Vanaf 1994 was hij als onderzoekspsycholoog ook 
betrokken bij het onderzoeksproject gecombineerde behandeling van depressie aan het 
Psychiatrisch Ziekenhuis Amsterdam (thans Mentrum/Arkin). In 1998 werd hij psycholoog 
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